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CHAPTER I: STATEMENTOFTHEPROBLEM 
Background and Significance 
Tobacco use is the leading preventable cause of death, disease, and disability in the U.S. 
Each year, around 443,000 people die from smoking or exposure to secondhand smoke, and 
another 8.6 million suffer from a serious illness from smoking. There have been several 
recommendations and implications for physicians and other healthcare professionals to play a 
central role in motivating and assisting patients who smoke to quit (Fiore, M et al., 2008). 
Healthcare providers are a credible and trusted source of advice to quit, have opportunities to 
provide this message to most smokers, and can connect patients to cessation counseling and 
pharmacotherapy. These actions are economical and effective at increasing cessation rates 
(Macosek, 2006). 
About I in 5 adults smoke (45.3 million) and, although smoking prevalence has declined 
from 20.9% in 2005 to 19.3% in 2010, tobacco use is still the most common cause of preventable 
death and disease in the United States (Centers for Disease Control and Prevention, 2010). 
Smoking reduces the median survival of smokers on average by 10 years, and beyond the age of 
40, each additional year of smoking reduces life expectancy by three months (Doll, 2004). By 
stopping cigarette smoking, a patient reduces the risk of lung cancer and other diseases by up to 
90 % and improves survival, even if cessation occurs after the age of 50 years. Nonetheless, 
habitual smokers find it extremely difficult to successfully stop smoking. Although 70 % of 
smokers would like to quit, and 40 % make at least one stopping attempt per year, only three to 
four percent of smokers per year are successful in stopping long-term on their own (Messer, 
2007). The highest risk for relapse is within the first eight days after quitting. Active smoking 
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cessation interventions by the physician, a clinic staff member, or a counseling service (in-
service or telephone counseling) should be initiated before or within the initial week after the 
planned quit date (Hughes, 2004 ). 
As a result of tobacco use, primarily cigarette smoking, which is the leading cause of 
preventable morbidity and mortality in the United States (Mokdad, Marks, Stroup, Gerberding, 
2004), primary care providers have an opportunity to offer office-based smoking cessation 
interventions to the 70 % of smokers who visit their offices every year (Fiore., 2002). Primary 
care providers are in a strategic position to help their patients quit smoking. It has been estimated 
that at least 70 % of smokers see a physician each year, and 70 % also report a desire to quit and 
make at least one serious attempt to do so (Lancaster, Stead, 2004). In addition, smokers cite a 
physician's advice to quit as an important motivating factor for attempting to quit; brief advice 
from a physician leads to a spontaneous quit rate of two to four percent (Lancaster, Stead, 2004). 
The National Cancer Institute estimates that if 100,000 physicians were to assist ten percent of 
their patients who smoke to quit each year, the number of smokers in the United States would 
decrease at a rate of two million people annually (Ockene, 1987). 
Healthy People 2020 provide science-based, national goals and objectives with ten-year 
targets designed to guide national health promotion and disease prevention efforts to improve the 
health of all people in the United States. The Healthy People 2020 Tobacco Use objectives are 
organized into three key areas. The first is the Tobacco Use Prevalence, which involves 
implementing policies to "reduce tobacco use and initiation among youth and adults" 
(CDC.gov). Providing educational tools in the school system to encourage cessation, 
particularly at the middle and high school levels, has been an implementation at the local Health 
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Departments across the state of Tennessee. The second is the Health System Changes, which is 
"adopting policies and strategies to increase access, affordability, and use of smoking cessation 
services and treatments" (CDC.gov). The ability to access information from the CDC website 
and acquire brochures, handouts, and website information to view, plus educating at the point of 
care has been utilized and proven efficacious in the local Health Departments here in Southeast 
Tennessee. Social and Environmental Changes is the third objective by "establishing policies to 
reduce exposure to secondhand smoke, increase the cost of tobacco, restrict tobacco advertising, 
and reduce illegal sales to minors" (CDC.gov). Each objective includes a nationally 
representative and reliable data source, baseline estimate, and target for specific improvements to 
be achieved by the year 2020 (CDC.gov). 
Wadland et al, demonstrated that physicians and their staffs can be trained to 
successfully deliver office-based smoking cessation interventions and that these interventions 
significantly improve smoking cessation rates (Wadland, Stoffelmayr, Berger, Crombach, Ives. 
Enhancing, 1999, Katz, Muehlenbruch, Brown, Fiore, Baker, 2005). Meta-analyses of 
randomized trials have found a strong dose-response relationship between the duration of 
counseling (both number of sessions and length of each session) and abstinence rates 
(Fiore et al., 2008). Clinician counseling sessions greater than ten minutes more than double the 
rate of abstinence compared to no counseling. Clinician counseling may consist of multiple 
visits, often weekly, starting before the quit date and continuing for one to two months after the 
quit date to optimally support a smoker through the quitting process. These programs are more 
effective than simple self-help interventions, in which smokers are provided with take-home 
print or audiovisual material to aid them in quitting on their own (Coleman, 2004). Self-help 
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interventions have proven to be ineffective when offered alone, although take-home materials 
can augment the efficacy of clinician counseling (Landcaster, 2005). 
Currently, Utah has the lowest smoking rate; fewer than ten percent of adults in Utah 
smoke cigarettes. Kentucky and West Virginia have the highest smoking rates; nearly 26% of 
adults smoke in both states. Fewer people smoke in the West (about 16%), and more people 
smoke in the Southeast (about 22%) and Midwest (about 23%) (cdc.gov/vital signs/Tobacco 
Use/Smoking/index.html). 
Most individuals with an addiction to cigarettes started smoking before they turned 18 
years old. Tennesseans under the age of 18 will purchase and consume over 16.8 million packs 
of cigarettes this year (www.tobaccofreekids.org). Approximately 7,600 young people in 
1'ennessee become new )'outb smokers each )'ear, and L\\2,l)l)l) oftoda)''s 1'ennessee cb\\dren 
will become smokers; 132,000 of them will die prematurely from tobacco related causes 
(www.tobaccofreekids.org). Unfortunately, most of the patients seen in the primary care setting 
in Southeast Tennessee, those who are uninsured or underinsured, already smoke and have 
negative repercussions from their years of tobacco use. 
The once commonly held belief that smoking tobacco was harmless, and perhaps even 
good for some, was shattered on January 11, 1964. The first U.S. Surgeon General's report on 
smoking was issued that day, alerting Americans, and the world, to the deadly consequences of 
smoking. In the 50 years since that report, the U.S. and Tennessee have made remarkable 
progress, cutting smoking rates significantly, protecting much of the population from harmful 
secondhand smoke, and saving millions of lives. Still, the battle against tobacco is far from won, 
and too many people develop or sustain addictions to tobacco products. 
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"Tobacco use kills more than 440,000 Americans, including 9,700 Tennesseans, every 
year; it sickens millions more and costs Tennessee $2.6 billion of the nation's $193 
billion in healthcare bills and lost productivity," said Tennessee Department of Health 
Commissioner John Dreyzehner, MD, MPH. "Our state is near the bottom, 47th, in 
smoking rates with a quarter of all adults and more than one in five high school students 
currently smoking. This is terrible. We can and must do a better job in preventing young 
people from starting an addiction to nicotine, preventing children and others from being 
exposed to harmful secondhand tobacco products, and encouraging people to quit through 
programs like 1-800-QUIT-NOW" 
(Media Release: http://news.tn.gov/taxonomy/term/30, January 14, 2014). 
Officials with the Centers for Disease Control and Prevention say the tobacco industry 
spends eight billion dollars annually, or nearly one million dollars per hour, on marketing and 
recruiting two new young smokers for every adult who dies from tobacco-related illness. That 
equates to about $28 per U.S. resident per year. The CDC also reports that states collect about 
$80 per person per year in tobacco taxes and settlement funds but only spend, collectively, about 
$1.50 per year per person on tobacco prevention ( cdc.gov). Up to one-half of all tobacco users 
can be expected to die from a tobacco-related disease. The economic burden of tobacco use is 
estimated to be $197 billion per year, which includes $96 billion in health care costs and an 
additional $97 billion in productivity losses (World Health Organization Report on the Global 
Tobacco Epidemic, 2011 ). 
The most important causes of smoking-related mortality are atherosclerotic 
cardiovascular disease (CVD), lung cancer, and chronic obstructive pulmonary disease (COPD) 
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(CDC - MMWR 2009). Tobacco use also increases the risk of many other acute and chronic 
diseases, including cancers at many sites other than the lung. An estimated 30 % of cancers in 
the US are tobacco-related (US Department of Health and Human Services, 2005). Smoking 
cessation is associated with clear health benefits and should always be a major health care goal. 
Screening all patients for tobacco use and providing all smokers a brief smoking cessation 
intervention is one of the three most cost-saving clinical preventive services (Maciosek, et al., 
2006). 
Tennessee and many other states are using the 50th anniversary of the Surgeon General's 
report on tobacco to emphasize three shared national goals: l) Reduce smoking rates to less than 
ten percent within ten years; 2) to protect all Americans from secondhand smoke within five 
years; and 3) ultimately eliminate death and disease caused by tobacco. The mission of the 
Tennessee Department of Health is to protect, promote and improve the health and prosperity of 
people in Tennessee (http://health.state.tn.us/). 
Prevalence and Tobacco use Patterns 
The prevalence of smoking cigarettes among Unites States (US) adults has declined from 
42.4 % in 1965 to 19.3 % in 2010 (CDC Report, 2011 ). However, there has been little decline in 
adult smoking prevalence since 2005 in contrast to the dramatic declines of past decades. Not all 
smokers are daily smokers; 78 % of smokers smoke every day while 22 % smoke less frequently 
than daily (CDC Vital Signs, 2009). 
The pattern of tobacco use in the U.S. varies among socio-demographic groups. A large 
gender gap in cigarette smoking existed in the 1960s, when over 50 % of men and only about 
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25 % of women smoked. This gap has narrowed but not disappeared. Currently, 21.5 % of men 
and 17.3 % of women smoke cigarettes (CDC Vital Signs, 2011). 
Today, the largest disparities in tobacco use occur in groups defined by education, 
income, race, and ethnicity. More than one-quarter (28.4 %) of individuals without a high school 
diploma smoke cigarettes, compared to only 11.1 % of adults with a college degree. Individuals 
who have passed the General Education Development (GED) tests smoke at an even higher rate 
(49.1 %) than those without a high school diploma. The CDC also notes current statistics 
regarding adults with education levels at or below the equivalent of a high school diploma, who 
comprise nearly half of current smokers, which have the lowest quit ratios 39.9 to 48.8 % (CDC 
Vital Signs, 2011 ). 
Adults with incomes below the federal poverty level are significantly more likely to 
smoke than adults with higher incomes (28.9 versus 18.3 %) (CDC-Vital Signs. MMWR, 
2007). Among racial and ethnic groups, smoking prevalence is similar between Caucasians 
(22.1 %) and African-Americans (21.3 %) and is lower among Hispanics (14.6 %) and Asians 
(12.0 %). Many current smokers are trying to quit. Forty percent of daily smokers report that 
they did not smoke for more than 24 hours in the past year because they were trying to quit. This 
rate is even higher among young adult smokers (aged 18 to 24 years), over half of whom made a 
quit attempt in the past year (Centers for Disease Control and Prevention (CDC). Vital signs: 
current cigarette smoking among adults aged >or=l8 years --- United States, 2009. MMWR 
Morbidity Mortal Weekly Rep 2010; 59:1135). 
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Patterns of tobacco use 
Turner (2007) concluded his research and noted that almost every adult who currently smokes 
started smoking by the age of 18. Half of high school students have tried smoking a cigarette, 20 
% have smoked a cigarette in the past 30 days, and 8 % smoked frequently, defined as smoking 
on 20 of the past 30 days (CDC, 2008). Past-month smoking rates among twelfth-grade high 
school students increased during the 1990s, peaking at 36.4 % in 1997, and have since declined 
to 20 % (CDC 2008). 
The earlier the age at which a person begins smoking, the more likely he or she is to 
continue into adulthood (Maciosek, Coffield , Edwards, et al., 2006). Within a year of smoking 
initiation, children inhale the same amount of nicotine per cigarette as adults and experience the 
craving and withdrawal symptoms, and, unfortunately, tobacco dependence can develop very 
quickly in children (DiFranza, Savageau, Fletcher, et al., 2007), although the amount smoked 
may increase for a number of years. By the time they are 20 years old, 80 % of young smokers 
regret ever having started (Jarvis, 2004). 
Risk factors for an adolescent becoming a smoker include having parents or friends who 
smoke, living with a smoker, having a strained relationship with a parent and/or single parent at 
home, low level of self-esteem and self-worth, poor academic performance, increased perception 
of parents' approval of one's smoking, comorbid psychiatric disorders, and the availability of 
cigarettes (Maciosek, Coffield, Edwards, et al., 2006). An additional risk factor for boys is high 
levels of aggression and rebelliousness, and for girls, preoccupation with weight and body image 
is a separate risk factor (Maciosek, et al,. 2006). Studies that involved twins have shown a 
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significant genetic link to both smoking initiation and dependence, although it is likely that they 
involve different genes (Swan, 1999). 
Nicotine Sources 
In addition to cigarettes, tobacco is also smoked in the form of cigars, pipes, and water-
pipes. Tobacco in the form of chewing tobacco and snuff is not smoked but is absorbed through 
the buccal mucosal membrane. Electronic cigarettes (e-cigarettes) use a liquid nicotine cartridge, 
rather than tobacco. 
The smoke from cigars and pipes is not typically inhaled as deeply into the lungs as is 
cigarette smoke and, for this reason, the risk of lung cancer from smoking cigars and pipes is 
lower than the risk of smoking cigarettes, but higher than the risk of a nonsmoker 
(www.cdc.gov/tobacco/sgr/sgr 2004/index.htm). 
The use of water pipes (also known as hookah) to smoke tobacco is an emerging form of 
tobacco smoking in the US, especially among young adults (Primack, Sidani , Agarwal, et al., 
2008). Currently, there is only one Hookah lounge located in Hixson, Tennessee. This is a 
traditional form of tobacco use in the Middle East and the amount of nicotine and toxins varies 
based on the type of tobacco used and how it is smoked. Water-pipe smoking is also associated 
with lung cancer and other respiratory diseases (Akl, Gaddam, Gunukula, et al., 2010). One 
meta-analysis of six cross-sectional studies found that waterpipe smoking negatively affects lung 
function, particularly in reducing forced expiratory volume in one second (FEVl) and is likely to 
be a cause of obstructive lung disease (Raad, Gaddam, Schunemann, et al., 2011 ). 
Smokeless tobacco is available as chewing tobacco or snuff. Different processing 
techniques, particularly "curing", can result in markedly different contents of toxins in smokeless 
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products. About three percent of adults in the US use smokeless products, primarily white males 
of lower socioeconomic status in the southern or western US. Smokeless tobacco is not 
harmless, although the health risks for certain diseases may be substantially less than with 
smoking. It may also cause cancer of the oral cavity and provides sufficient nicotine exposure to 
cause nicotine addiction (Scientific Committee on Emerging and Newly Identified Health Risks. 
Health effects of smokeless tobacco products. Available at 
ec.europa.eu/health/ph _risk/ committees/04 _ scenihr/ docs/scenihr _ o _ 013. pdf). 
Electronic cigarettes ( e-cigarettes) use an electronic delivery system that aerosolizes 
nicotine, producing a vapor similar to cigarettes but containing fewer traditional toxins (Yamin, 
Bitton, Bates, 2010). E-cigarette devices are composed of three parts: a plastic tube, an electronic 
heating element, and a liquid nicotine cartridge. The user presses a button that simultaneously 
releases a puff of vaporized nicotine while illuminating the device tip (that simulates the lit end 
of a cigarette). E-cigarettes do reduce the desire to smoke traditional cigarettes and have been 
prescribed by clinicians to aid in smoking cessation (Bullen, McRobbie, Thomley, et al., 2010). 
They are being increasingly used by the general population, mostly as a result of internet 
advertising and sales. There are many available products that vary greatly in consistency, in 
nicotine delivery, and in other additives that may have their own toxicity. A 2009 US Food and 
Drug Administration (FDA) report one-cigarettes found trace amounts of the harmful solvent 
diethylene glycol as well as nitrosamines which are known carcinogens. This report also found 
nicotine in 'light' e-cigarettes that were labeled as being nicotine-free. The FDA has not 
approved the use of any e-cigarettes given safety concerns, particularly related to use in 
adolescents and potential toxic ingestion among children (fda.gov, 2010). Data from one pilot 
PRACTICE CHANGE 15 
study reports common adverse effects of e-cigarettes as dry cough and irritation in the 
oropharynx (Polosa, Caponnetto, Morjaria, et al., 2011 ). Whether initial recreational use of e-
cigarettes leads to smoking of conventional cigarettes is still unknown. 
Despite their increasing popularity, little is known about e-cigarette use, potential for 
addiction, or long-term health effects from smoking and second-hand smoke. Whether e-
cigarettes can help smokers to quit or permanently stop using tobacco products is uncertain 
Rigotti, 2012). A randomized trial that compared e-cigarettes with nicotine patches among 
smokers who wanted to quit found no significant difference in the cessation rates produced by 
the two treatment arms, although the study was underpowered and could have missed important 
differences in the effectiveness of e-cigarettes compared with patches (fda.gov, 2010). While this 
trial suggests that e-cigarettes might have the potential to be smoking cessation aids, further 
studies will be required to establish the efficacy and safety of e-cigarettes for cessation. 
Purpose 
The US Public Health Service Smoking Cessation Clinical Practice Guideline 
recommends that all clinicians, including nurses, strongly advise their patients who use tobacco 
to quit (Fiore, Bailey, Cohen, Dorfman, Goldstein, Gritz, et al., 2000). 
The primary purpose of this doctoral scholarly project is to address the growing smoking 
epidemic concern in the Southeast Region of Tennessee with adults aged 19 to 64 years who are 
uninsured who seek care at the local health departments, specifically Sequatchie County Health 
Department. A practice change is proposed and would entail a request for the addition of the 
patient's current smoking status as an entity of the vital signs, and an assessment to determine 
the current stage of change according to the Transtheoretical Model. Changing or modifying a 
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behavior that is addictive or potentially harmful is difficult for most people. The Transtheoretical 
Model (TTM) (Prochaska, Norcross, & DiClemente, 1994) incorporates a compilation of 
previous theories, providing a framework for the stages of progression when deciding to change 
a problematic behavior. The proposal would include an algorithm which would serve as a guide 
for primary care providers (PCPs) encompassing the TTM, and would also comprise a 
recommendation for the evaluation. These three components of the proposal would be in addition 
to the already established Quit-line that is currently being utilized. 
The goal of this practice change would be to provide improved patient care by increasing 
provider's adherence to the recommendations of a clinical practice guideline for the assessment 
and treatment of smoking cessation in the primary care setting. 
Practice Setting 
The setting for this study will be one of the primary care sites in the Southeast Regional 
Health Departments, Sequatchie County Health Department. Primary care is provided at this 
rural site where approximately 50-60 patients receive primary care weekly. The clinic's 
population is largely made up of Caucasians as well as a small number of African Americans and 
Hispanics. The majority of patients are between the ages of 19-65 years for primary care. The 
clinic also provides Family Planning, provides services from a state run program for women, 
infants and children (WIC), children with special needs (CSS), sexually transmitted infections 
and diseases (STD). 
The support of this scholarly project of addressing the growing epidemic concern of 
smoking in the Southeast Region was initially discussed with the Southeast Regional medical 
director who oversees all seven health departments of which only three currently provide 
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primary care. For this doctoral project, the practice change emphasis will be focused on the three 
primary care sites which are Sequatchie County Health Department in Dunlap, Grundy County 
Health Department in Altamont and Bradley County Health Department in Cleveland, 
Tennessee. 
Definitions 
Southeast Region Health Department 
The Tennessee Department of Health is comprised of eight regions across the state of 
Tennessee of which Southeast Region is one, which is further subdivided into counties including 
Bledsoe, Bradley, Franklin, Grundy, Hamilton, McMinn, Marion, Meigs, Polk, Rhea, and 
Sequatchie. The mission of the Tennessee Department of Health (TOH) is to protect, promote 
and improve the health and prosperity of people in Tennessee. All 6.45 million Tennesseans, 
along with those who visit our state, are touched directly or indirectly by TOH operations. One in 
five, approximately 1.4 million people, are directly served each year through a network of 89 
rural and six metropolitan county health departments. Others are affected by inspections of 
restaurants, healthcare and related facilities; registration or receipt of vital records; protection 
from communicable illness; licensing of health professionals; specialized laboratory testing and 
many other services and programs. 
Protecting people's health by preventing problems that contribute to illness, disease and 
injury is the overall emphasis of the department. Contrary to popular belief of only 
administration of immunizations at the Health Department, other crucial and indispensable 
responsibilities include screening, providing and assuring a safety net of care, particularly in 
medically underserved populations and areas of Tennessee; offering early prenatal care and 
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proper nutrition to pregnant women and young children; and assuring restaurants, hotels, health 
facilities and health professionals meet requirements and standards established in Tennessee 
code. The regulatory work performed by the department impacts more than 10 % of Tennessee's 
gross domestic product and more than 14 % of its workforce 
(http:/ !health.state. tn. us/ ems/RegionalOffice.htm ). 
The greatest causes of premature death and preventable illness are closely related to the 
way we live including what and how much we eat, whether we use tobacco, how much we 
exercise, and what we do to protect our safety. The TDH emphasizes health protection, primarily 
preventing illness and injury from occurring in the first place. By promoting healthy lifestyles 
that avoid health risks and educating Tennesseans about the rewards we enjoy when we protect 
the health of our communities, our families and ourselves, we are all able to enjoy better health. 
QuitLine 
The Tennessee Tobacco QuitLine is a toll-free telephone service that provides 
personalized support for Tennesseans who want to quit smoking or chewing tobacco. When an 
individual calls the QuitLine, they are assigned their own quit coach who then assists them in the 
knowledge and understanding of how to quit using tobacco. Assistance in developing a 
personalized plan that works for them plus the added advantage of having the same quit coach 
for an entire year. The quit coach helps individuals figure out what works best for them. With 
this program, the coach doesn't tell them what to do, but rather a collaborative effort is 
encouraged with a quit coach to make changes that fit the individual's life. In addition to the 
QuitLine at Sequatchie County Health Department, a smoking survey is completed on an initial 
and annual visit to ascertain the patient's current usage of tobacco. 
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Patient Tobacco Survey 
The Patient Tobacco Survey is a six question multiple choice questionnaire with pointed 
questions directly related to tobacco usage completed by the patient on initial and annual 
appointments. This survey is completely voluntary and includes a 'refused' option as one of the 
multiple choice answers. Patients are then questioned based on the answers on the questionnaire, 
and then the provider has the opportunity to address their smoking cessation status 
(Appendix A). 
Health Promotion 
Health promotion and disease prevention are essential competencies for nursing at the 
doctorate of nursing practice level (American Associatiotvof Colleges of Nursing, 2006). Health 
promotion is often cited as a distinguishing feature of nursing in comparison to the more disease 
focused practice of physicians. It is the provision of services or implementation of processes that 
advance health beyond simply preventing or eliminating illness to building capacity that enables 
individuals and groups to improve their health and well-being (Hutchinson, et al., 2006; 
Kiekbusch, 2003; Larson, 1999). Although health promotion and disease prevention are often 
used interchangeably, their scope, underlying motivations, and purposes are unique. Health 
promotion has a broad scope that encompasses the whole client, including bio-psychosocial, 
cultural dimensions spiritual and the client's environment. Health promotion assists clients to 
optimize health and well-being, attain balance, stability, and harmony, strengthen adaptation and 
expand consciousness (M.P. O'Donnell, 1989, 2009,; Smith, 1990), Health promotion activities 
include, but are not limited to, the prevention of disease or decreasing risk factors for disease 
(Pender, Mardaugh, & Parsons, 2006; Smith, 1990). 
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Program Evaluation 
Program evaluation is the systematic inquiry of a program's activities, characteristics, 
and outcomes to provide information for decision-making related to the program, to improve 
program quality or effectiveness, or to inform future programs. Program evaluation is an 
essential element of translating, sustaining, and improving health promotion programs. Various 
approaches, models, and categories or types of evaluation serve as guides in conducting 
evaluation projects. The selection of frameworks depends on the purpose of the evaluation, the 
resources available, and planned use of the findings (Appendix F). 
Five "A's" 
The five "A''s are used to assess for tobacco use and address smoking cessation. The 
interventions include: 
• Ask- Implement an office-wide system that ensures that, for every patient at every clinic 
visit, tobacco-use status is queried and documented. 
Advice- Strongly urge all tobacco users to quit in a clear, strong, personalized manner. 
Assess- Determine the patient's willingness to quit smoking within the next 30 days. 
Assist- Provide aid for the patient to quit. 
Arrange- Schedule follow-up contact, either in person or by telephone. Follow-up contact 
should occur soon after the quit date, preferably during the first week. A second follow-
up contact is recommended within the first month. Schedule further follow-up contacts as 
indicated. Congratulate success during each follow-up. If tobacco use has occurred, 
review circumstances and elicit recommitment to total abstinence. Remind the patient 
that a lapse can be used as a learning experience. Identify problems already encountered 
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and anticipate challenges in the immediate future. Assess pharmacotherapy use and 
problems. Consider use or referral to more intensive treatment (Fiore MC, Jaen C, Baker 
T, et al., 2008). 
Theoretical Framework 
Health promotion and risk reduction are processes that advance health beyond simply 
preventing or eliminating illness to building capacity that enables individuals and groups to 
improve their health and well-being (Hutchinson et al., 2006; Kiekbusch, 2003; Larson, 1999). 
Assessing, implementing, and evaluating strategies that affect health is a complex undertaking 
that requires knowledge of comprehensive, logical, relevant theories and models. A theory has 
been defined as an abstract generalization that offers a systematic explanation of how variables 
are interrelated (Polit & Beck, 2008). Theories tell how and why things work and how and why 
one variable is related to another. The Transtheoretical Model (TTM), CREATION, and the Self 
efficacy theories are appropriate theories used to explain the phenomenon of interest of smoking 
cessation in the primary care setting (Prochaska, 1992; CREATION Health, 2008; Bandura, 
1986). 
Transtheoretical Model (TTM) 
Prochaska and DiClemente's stage of change model, the Transtheoretical Model (TTM), 
is a contemporary psychological model of behavioral change employed to develop efficient 
interventions to promote healthy behavioral changes. Interventions can be individualized to the 
needs of individuals in order to achieve optimal results (Tang, Chen, & Chen, 2009). The TTM 
emphasizes the importance of the readiness for change, hypothesizing that progress through the 
stages of change is influenced by the pros and cons of changing, self-efficacy, cognitive and 
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behavioral processes (Prochaska, Redding, & Evers, 2002). The premise of the TTM is that a 
behavior change is a process, not an event, influenced by motivation levels. It also outlines how 
people make deliberate changes, especially eliminating problem behaviors and beginning new, 
healthier behaviors. Behaviors generally progress from low awareness and no intention to 
change, through high awareness and active efforts to initiate or maintain change. Behaviors also 
emphasize the importance of the readiness for change, hypothesizing that progress through the 
stages of change is influenced by the pros and cons of changing, self-efficacy, with cognitive and 
behavioral processes (Prochaska, Redding, & Evers, 2002). 
According to Prochaska ( 1994) the TTM behavior change is seen as a process that progresses 
from low awareness and no intention to change, through high awareness and active efforts to 
initiate or maintain change The first stage of the TTM is: 
Pre-contemplation which is characterized as not currently considering change. During 
this stage, individuals validate their lack of readiness. Clarification of decision making is 
discussed, and re-evaluation of current behavior and self-exploration are encouraged. 
The second stage is Contemplation where individuals are ambivalent about the 
impending change or perhaps recognition of the problem and serious thought about the 
changes are evident. 
Preparation is the third phase where there is a conscientious decision to change within a 
timeframe of one month. There may be some experience with change where persons are 
trying to change and assistance in problem solving regarding obstacles may need to be 
investigated and explored. 
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Action or practicing the new behavior for approximately three to six months is the 
characteristics of this forth stage of change. The techniques implemented here focus on 
restructuring cues and social support, bolstering self-efficacy for addressing obstacles and 
combating feelings of loss. 
The fifth stage of change is maintenance where there is a continued commitment to 
sustaining the new behavior for greater than six months. The techniques involved in this 
stage of change include a plan for follow-up support, and the discussion of coping with 
the potential of relapse (Prochaska, Redding, & Evers, 2002). 
At the three primary care sites, each of the above mentioned five stages of change will be 
proposed to be included in the vital signs component section of the progress notes. Interventions 
may then be individualized to the needs of individuals in order to achieve optimal results. 
CREATION Health Model 
Florida Hospital is a Christian, faith-based hospital that believes in providing Whole 
Person Care to all patients - mind, body and spirit, through the principals of CREATION Health. 
CREATION Health is God's plan for living. This wellness program is based on Biblical 
principles found in the Creation story and supported by evidence-based science. Learn the best 
practices of whole person living - mentally and physically along with a strong focus on 
spirituality and faith. CREATION Health is the 8 principle acronym that defines the way Florida 
Hospital provides Whole Person Care to all patients-mind, body and spirit (CREATION 
Health.com). 
Choice is the first step toward improving one's wellbeing according to the CREATION 
model (2011 ). Before one can achieve positive changes in any area of their lives, they must 
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choose to do so. Conscious decision-making is fundamental and essential to experiencing the 
positive impact of good choices. Deci, Speigel, et al ( 1982) state that providing one with the 
ability to choose increases an individual's sense of personal control and feelings of intrinsic 
motivation. The authors concluded that choices have powerful motivating consequences and 
conversely, the absence of choice and control has a variety of detrimental effects on intrinsic 
motivation, life satisfaction, and one's wellbeing. Ultimately, smokers have the innate ability of 
choice to be exercised and applied. 
Other entities of the CREATION model that could be relevant are Outlook, Nutrition 
and Interpersonal relationships which may be directly applied and appropriated in the primary 
care setting. Outlook refers to how individuals view the world, their lives, and their circle of 
influence. Outlook also impacts everything one thinks about and does and is essentially a 
person's general attitude. Seligmnan ( 1998) studied the effects of optimism and pessimism and 
concluded that becoming an optimist consists of simply learning a set of skills about how to talk 
to oneself when suffering a personal defeat and as the optimism increases, addressing setbacks 
will be accomplished from a more encouraging perspective. In the primary care setting, outlook 
may be perceived from the practitioner's encounter which may be a valuable entity in assessing 
the stage of change regarding smoking cessation. 
Nutrition is one of the most powerful tools we have to promote health and by so doing we 
can substantially increase disease prevention and be healthier, happier and more energetic 
(Willett, 1994). Science has demonstrated that fruits and vegetables are incredible promoters of 
harmonious living. A study done on Chinese women in Singapore- a city in which pollution 
levels are often high- showed that in non-smokers, eating cruciferous vegetable lowered their 
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risk of lung cancer by 30%. In smokers, regularly eating cruciferous vegetables reduced lung 
cancer risks an amazing 69% (Zhoa, Seow, et al., 2001). Incorporating a healthy, balanced diet 
including nuts, seeds, whole grains, large amounts of water to maintain a well hydrated body, 
and consuming breakfast daily are wise decisions that individuals can make about nutrition 
which can have rich health rewards (CREATION, 2011). The need to introduce to some 
smokers and encouraging others toward a healthy balanced diet during encounters in the primary 
care setting, could potentially be a positive entity for smoking cessation. 
Social connectedness and health have been recognized and evaluated in Dr. Dean 
Omish's intervention for reversing heart disease. Interpersonal relationships were a surprising 
discovery from his perspective. He pointedly states "I'm not aware of any other factor in 
medicine - not diet, not smoking, not exercise, not stress, not genetics, not drugs, not surgery -
that has a greater impact on our quality of life, incidence of illness and the premature death from 
all causes than does love and intimacy" (Omish, 1998 pg 2-3). To harmonize with Omish's 
study, Stead (2005) concluded that group therapy allowed smokers to learn behavioral 
techniques among their peers, with the intent of providing mutual support among group members 
and it is nearly twice as efficacious as self-help programs (Stead, Lancaster, 2005). 
Self-efficacy Theory 
According to Bandura (1986), self-efficacy is the most important precondition for 
behavior change. Self-efficacy is the belief that one has the power to produce an effect by 
completing a given task or activity related to that competency. It also relates to a person's 
perception of their ability to reach a goal, is the belief that one is capable of performing in a 
certain manner to attain certain goals, and is based on the premise that it is an expectation that 
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one can master a situation and produces a positive outcome. The three major factors that 
influence self-efficacy are behaviors, environment, and personal and cognitive factors. They all 
affect each other, but the cognitive factors according to Bandura are most important. Bandura 
also postulates that motivation, performance, and feelings of frustration associated with repeated 
failures will determine effect and behavior relations. (Bandura, 1986). 
The three primary care sites of the Southeast Regional Health Departments serve the 
uninsured where the providers encourage patients to master their specific situations to produce 
positive outcomes. Smoking is rampant in these particular communities so empowering the 
patients who have expressed a desire to quit their tobacco abuse is sanctioned and encouraged. 
Practice Change Model 
Rosswurm and Larrabee ( 1999) developed a change model which guides practitioners 
through the full process of evidence-based practice (EBP). The model is based on theoretical and 
research literature related to evidence-based practice, research utilization, standardized language, 
and change theory. In this model, practitioners are guided through the entire process of 
developing and integrating an evidence-based practice change. The model supports evidence-
based practice changes derived from a combination of quantitative and qualitative data, clinical 
expertise, and contextual evidence (Holleman, Eliens, van Vliet, & van Achterberg, 2006). It 
includes six steps: assessing the need for change, identifying potential interventions and 
outcomes, synthesizing the best evidence, designing a practice change, implementing and 
evaluating the practice change, and integrating and maintaining the practice change. 
(See Figure 1 ). 
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The mission of the Tennessee Department of Health (TDH) is to protect, promote and 
improve the health and prosperity of people in Tennessee. All 6.45 million Tennesseans, along 
with those who visit our state, are touched directly or indirectly by TDH operations. 
The current practice protocol regarding assessments of patients who smoke entails an 
initial and annual smoking survey that is done by the primary care provider. The information is 
then entered in a data base and later on evaluated by the Health Department's epidemiologist. In 
the past year and a half, the project manager for this practice change proposal have seen patients 
who have returned for their three month follow up and annual visits with essentially the same 
answers. Unfortunately, the information gained becomes 'invisible' to the providers, but per the 
current protocol, assessment of the patient's current smoking status should be asked with every 
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encounter. Interventions presently integrated include referring the patients to other providers, 
advising over-the-counter cessation medications, and prescribing pharmacologic agents such as 
Bupropion and Varenicline. Provision of the Tennessee Quit Line information brochure which 
encourages patients to call and will have the ability to speak with a 'quit coach' and learn how to 
deal with tobacco cravings and other challenges is also distributed during an encounter. 
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CHAPTER 2: LITERATURE REVIEW 
Introduction 
In recent years, there has been a proliferation of research studies on the effect of smoking 
and the negative ramifications in terms of health and quality of patient outcome. The following 
is a discussion and summary of evidence based literature reviews related to smoking cessation in 
the primary care setting. The studies were done in the United States, Europe, Asia and Canada 
and include quantitative and qualitative studies as well as meta-analyses spanning the years of 
1995-2014. The project manager began the search using EBSCO, CINAHL, Pub Med, the 
Cochrane Review and Health Sciences. The following key words and combinations were used: 
Smoking Cessation in primary care, overview of smoking cessation in management in adults, 
barriers to smoking cessation and relapse prevention. 
On review of nursing research literature, the implementation of evidence-based tobacco 
treatment guidelines into practice demonstrated that changes in the health care delivery system 
and clinical workflow patterns can have an extensive effect on cessation rates. Due to the 
plethora of available literature regarding smoking cessation, this literature review will pertain 
only to the primary care setting. 
Findings 
Technology 
The role of technology in improving systems approaches to tobacco treatment has been 
recognized as a positive asset for primary care providers. Information obtained via technology 
can reduce complexity and customize smoking cessation information through tailored cessation 
education printed "on the fly" (Shiell, Hawe, & Gold, 2008). The recently enacted American 
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Recovery and Reinvestment Act of 2009 calls for a $19 billion stimulus package to invest in 
health information technology (Mandi & Kohane, 2009), including $17 .2 billion for financial 
incentives to physicians and hospitals through Medicare and Medicaid to promote the use of 
EHRs (Steinbrook, 2009). This investment represents an unprecedented opportunity to the 
tobacco control research community to develop and test technologies to support evidence-based 
tobacco treatment. 
Ellerbeck, Ahluwalia, Jolicoeur, Gladden, & Mosier (2001 ), determined via an 
observational study in the primary care setting that having an assigned smoking cessation non-
physician staff member actually increased the frequency of tobacco-related discussions during an 
encounter, although this was not a significant smoking cessation predictor. In one particular 
practice, an assigned nurse was designated to provide tobacco cessation intervention and follow-
up utilizing technology, and smoking behaviors were addressed in 90% of all patient encounters 
with smokers. 
Despite the benefits of smoking cessation, clinicians are not adequately screening and 
treating patients who smoke. One study, for example, found that only 50 % of smokers seeing a 
primary care physician in the past year were asked about their smoking or urged to quit 
(AnAnda, Remington, Sienko, Davis, 1987). An even smaller proportion was counseled to quit. 
Some of the barriers to clinician intervention include time constraints, a perception that the 
clinician lacks the skills necessary to be effective in this role, and low expectation of successfully 
getting smokers to quit (JAMA, 1987). 
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Smoking Cessation Guidelines 
Practice guidelines calling for the treatment of all tobacco users have been released by 
the Agency for Health Care Policy and Research (AHCPR) and the United States Preventive 
Health Service. These were based on an exhaustive systematic review and analysis of the 
scientific literature from 1975 to 1999, and were published in the year 2000 (JAMA 2000). The 
American Psychiatric Association (APA) also released nearly identical guidelines (Am J 
Psychiatry, 1996). Clinicians now have available a clearly defined standard of screening and 
intervention to use with their patients. 
The field of smoking cessation treatment itself also is rapidly expanding. Randomized 
controlled trials of commonly used smoking cessation techniques, including individual, group, 
and telephone counseling, have demonstrated success in helping smokers quit and maintaining 
long-term abstinence (JAMA, 2000). In addition, rapid expansion in pharmacotherapy has 
resulted in multiple drug agents and systems of delivery directed at treating the biologic basis of 
tobacco addiction. 
The AHCPR guidelines recommend that the tobacco use status of every patient treated in 
a healthcare setting be assessed and documented at every visit (JAMA 2000). This practice has 
been shown to increase the likelihood of smoking-related discussions between patients and 
physicians and to increase smoking cessation rates, including smokeless tobacco, tobacco pipes 
and cigar smoking (Okuyemi, Ahluwalia, Wadland, 2001). 
Law, Tang, (1995), acknowledge the importance of specific advice to quit smoking, 
regardless of the patient's motivational status, which should be underscored. Every patient who 
smokes should be urged to quit in a clear, strong, and personalized manner. Not every patient 
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counseled on smoking cessation will be prepared to consider quitting. Nevertheless, it is 
important that the patient's smoking and motivational status be ascertained at each encounter. In 
a systematic review of 20 studies conducted in primary care settings, brief (less than five 
minutes) interventions that included advice to quit smoking resulted in two percent of all 
smokers quitting, compared with less than one percent of those who received no advice. 
A randomized trial found that informing patients of their "lung age" as determined by 
spirometry (age of a healthy person with the same lung function) doubled quit rates at twelve 
months (14 versus 6%) (Parkes, Greenhalgh, Griffin, Dent, 2008). The effect did not appear to 
be altered by whether the lung age was normal or abnormal. There is little evidence that other 
types of biomedical risk assessment increase smoking cessation rates compared to standard care 
(Bize, Burnand, Mueller, et al. 2009). 
The AHCPR has proposed the model of 115 Rs" in promoting motivation to quit smoking: 
(Appendix 8). 
• Relevance - Motivational information to a patient is more effective if it is relevant to a 
patient's circumstances (such as prior quitting experience, disease status, or health concerns). 
• Risks - The acute and long-term risks of smoking should be stressed. It is most effective 
if smoking can be tied to the patient's current health or illnesses. For the healthy patient, 
environmental risks, such as exposing spouses and children to smoking and thereby increasing 
their risk of ill-health should be included. Smokers should also be made aware that children of 
smokers are more likely to smoke. 
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Rewards - Encourage the patient to identify potential benefits of smoking (such as 
saving money, performing better in sports, improving the health of children and other 
household members, etc). 
Roadblocks - Ask the patient to identify barriers or impediments to quitting and note 
elements of treatment (problem solving, pharmacotherapy) that could address barriers. 
Repetition - Repeat the motivational intervention each time an unmotivated smoker 
visits the clinic setting. 
Barriers to Smoking Cessation 
The concept of perceived barriers has been used in behavioral medicine for a long time in 
one form or another. The earliest widespread use of the barriers concept was associated with the 
Health Belief Model. Webster's dictionary defines a barrier as "something that impedes or 
separates". Interestingly, the concept of barriers to accomplishment of a goal or a specified 
health behavior is assumed to be so straightforward that it is often left undefined. 
Gregory (2012), concluded that barriers to quitting smoking among the general 
population include psychosocial factors such as anxiety, and depression as well as smoking 
specific factors like motivation and self-efficacy to quit plus nicotine dependence. Of particular 
notation, there was a difference in younger and older smokers in the study's sample. Older 
smokers had a significantly lower level of nicotine dependence, stress, depressed mood, and a 
greater prevalence of smoking-related diseases. Older smokers were more likely to achieve 
biochemically verified abstinence at a 6-month follow-up than younger smokers (7 .8% vs 3.1 % 
respectively). Having a smoking related disease did not however, influence quitting among older 
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adults. For younger smokers, higher self-efficacy to quit and the presence of a smoking related 
disease increased the odds of abstinence. 
Kraemer et al. (2013) examined the role of emotional distress tolerance (DT) in 
predicting barriers to smoking cessation and number of quit attempts. The sample consisted of 
regular daily smokers (N= 126; 37 females; Mean age= 36.5 l , SD= 13.05) who completed self-
report measures on affect and smoking. The results indicated after controlling for daily smoking 
rate and anxiety sensitivity, emotional DT significantly predicted internal barriers to cessation 
(6.9% unique variance) but not external or addiction-related barriers to cessation. Inconsistent 
with prediction, emotional DT did not significantly predict number of quit attempts. The authors 
concluded that these results suggest that individuals who are low in emotional DT believe that 
quitting smoking will be difficult because it takes away an important affect regulation strategy. 
They additionally suggested there may be utility in targeting emotional DT in smoking cessation 
interventions (Kraemer et al., 2013 ). 
Fagan (2007) examined the relationship between smoking cessation counseling self-
efficacy, knowledge of smoking cessation counseling, motivation to counsel smokers, and 
barriers to performing smoking cessation counseling, relative to the smoking cessation 
counseling stage of change. Healthcare providers (N=296) completed a survey measuring the 
predictor variables of knowledge, motivation, self-efficacy and perceived barriers. The results 
indicated that the healthcare providers were knowledgeable about smoking cessation counseling 
and they had the self-efficacy to perform smoking cessation counseling effectively. The 
physicians also reported three significant barriers to smoking cessation counseling. The first 
listed was counseling time was not reimbursable by third party payers; secondly, smoking 
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interventions were not their responsibility due to lack of training; third, lack of resources for 
follow-up. There was a negative correlation between self-efficacy for smoking-cessation 
counseling and barriers to performing smoking-cessation counseling. The authors concluded that 
the study indicated that there was a moderate negative correlation between smoking cessation 
counseling self-efficacy and perceived barriers to performing counseling. This fact indicated 
that as self-efficacy increased, barriers decreased, specifying that environmental influences were 
associated with the level of self-efficacy (Fagan 2007). 
Carter-Pokras et al. (2011) studied and found that Latinos who smoke were less likely 
than non-Latino white smokers to use pharmaceutical aids such as nicotine replacement therapies 
or to receive physician advice to stop smoking. This qualitative study further explored barriers 
and facilitators to smoking cessation among Latino adults in Maryland. Participants were 
recruited through flyers, information sheets, and site visits at community health clinics and 
Latino events, and were predominately of Central American origin. The study revealed barriers 
and facilitators to smoking cessation among Latino adult tobacco users from both smokers' and 
ex-smokers' perspectives. The authors concluded a notable finding which was social influence 
(family, friends, or other social environment) played an important role in cessation among Latino 
smokers, serving as both positive and negative factors of influence for the initiation and success 
of quitting smoking. Favored by both current smokers and ex-smokers, lay health promoters 
were effective agents to reach Latinos with smoking cessation interventions. In addition, the low 
use of cessation services could have been improved by increasing awareness and availability of 
Spanish-language cessation services (Carter-Pokras et al. 2011 ). 
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The prevalence of tobacco use among urban African American persons aged 18 to 24 
years not enrolled in college is alarmingly high and a challenge for smoking cessation initiatives 
(Stillman, Bone, Avila-Tang, Smith, Yancey, Street, & Owings, 2007). The authors concluded 
from data collected from inner-city neighborhoods in Baltimore, MD, that more than 60 percent 
of young adults smoke cigarettes. Data from focus groups and surveys indicated that the sale and 
acquisition of "loosies" (single cigarettes) were ubiquitous and normative and may have 
contributed to the high usage and low cessation rates. This easy and affordable way to purchase 
cigarettes from street vendors and stores undermines tax policies, promotes smoking as a 
normative behavior, and may contribute to high smoking rates in some inner-city communities 
(Stillman et al., 2007). 
China has the largest number of smokers in any country in the world with a smoking 
prevalence of 66% in adult men and 3% in adult women (Yang et al. 2005). Yet, only 
a small proportion of current smokers ( 16%) have indicated an intention to quit (Yang et al. 
2001). Lam, Jiang, Chan, & Chee, (2011) conducted a cross-sectional survey of hospital-based 
healthcare professionals with direct patient contact. This was conducted in Guangzhou in 2006 
with a self-administrated questionnaire to investigate their practice of smoking cessation 
counselling, tobacco-related knowledge and attitudes, and perceived facilitators, barriers and 
organizational support to cessation intervention practices. Significantly more female physicians 
who were non-smokers (79.7%) reported "initiation and or advice" smoking cessation 
interventions than male physicians who were smokers (71.2%) and non-smokers (71.6% ). The 
findings highlighted the need for developing tailored smoking cessation training programs for 
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physicians according to their smoking status and gender in China (Lam, Jiang, Chan, & Chee 
2011). 
Caplan, Stout, & Blumenthal, (2011) researched a tobacco cessation program among 
African American physicians in private practice and healthcare providers at community health 
centers in GA. Data collection to determine tobacco-control practice behaviors among 
participating providers took place prior to training and at six months following training. 
Identified were six barriers to providing smoking cessation services which included lack of time, 
patient un-readiness to change, inadequate resources, language and culture barriers, patient non-
compliance, and inadequate cessation clinical skills on the part of the providers. Of these six 
barriers, the study's intervention addressed only two--inadequate cessation skills and inadequate 
resources-but this was sufficient to result in significant behavior change on the part of the 
participants. It was determined that the physicians' inadequate cessation skill was the most 
important barrier. This was not surprising, since medical students generally do not receive 
adequate training in approaches to smoking cessation. The study concluded that even though 
smoking cessation counseling was provided by non-physician staff with good results, it is 
likely that results will would be even better when it is a physician who provides-or at least 
initiates-the smoking cessation intervention, since patients typically accord physicians the 
most respect of any member of the health care team (Caplan, Stout, & Blumenthal, 2011). 
In a another study, Akpanudo, Price, Jordan, K.huder, & Price, (2009) researched and 
determined that the incidence of smoking among individuals suffering from various forms of 
mental illness was inordinately high which was approximately 60% overall, compared to 25% in 
the general population. The study also noted that clinical psychologists benefited from a number 
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of potential advantages in offering smoking cessation counseling and treatment where they have 
been specially trained in motivational techniques and have special expertise in helping patients 
change their behaviors. A cross-sectional study of clinical psychologists' smoking cessation 
practices and perceptions was the study's design. A random sample was surveyed regarding 
their smoking cessation practices and perceptions (N= 352) utilizing the 5A's and 5R's. The 
results indicated that counselors that had never smoked were almost two times more likely to 
have higher efficacy expectations than those that were current smokers or ex-smokers (OR= 
1.94, 95% CI 1.18- 3.12). The most frequently cited perceived barriers to providing smoking 
cessation counseling were "not the patient's presenting problem," "I do not see this as a priority 
for my client," and "may interfere with therapy goals." These findings portrayed that clinical 
psychologists were more concerned that smoking cessation counseling may interfere or be 
detrimental to the treatment of the primary mental health issue of the client even though studies 
have demonstrated that concurrent treatment approach to both the presenting mental health issue 
and tobacco use is feasible (Akpanudo, 2009). 
Cessation in Primary Care 
Law, Tang, (1995) acknowledges the importance of specific advice to quit smoking, 
regardless of the patient's motivational status, which should be underscored. Every patient who 
smokes should be urged to quit in a clear, strong, and personalized manner. Not every patient 
counseled on smoking cessation will be prepared to consider quitting. Nevertheless, it is 
important that the patient's smoking and motivational status be ascertained at each encounter. In 
a systematic review of 20 studies conducted in primary care settings, brief (less than five 
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minutes) interventions that included advice to quit smoking resulted in two percent of all 
smokers quitting, compared with less than one percent of those who received no advice. 
In a randomized controlled trial, Parkes (2008) examined the effect of smoking on quit 
rate utilizing spirometry in the primary care setting. The objective was to evaluate the impact of 
telling patients their estimated spirometric lung age as an incentive to quit smoking {N= 560) and 
aged over 35 years. Independently verified quit rates at 12 months in the intervention and 
control groups, respectively, were 13.6% and 6.4% (difference 7.2%, P=0.005, 95% confidence 
interval 2.2% to 12.1 %; number needed to treat 14). People with worse spirometric lung age 
were no more likely to have quit than those with normal lung age in either group. Cost per 
successful quitter was estimated at 280 pounds sterling (366 euros, $556). A new diagnosis of 
obstructive lung disease was made in 17% in the intervention group and 14% in the control 
group; a total of 16% (89/561) of participants. The study concluded that telling smokers their 
lung age significantly improves the likelihood of them quitting smoking, but the mechanism by 
which this intervention achieves its effect was unclear. 
A relatively new concept is that of "text messaging". Mobile phone text messaging 
allows patients to receive personalized smoking cessation support through a series of automated 
motivational messages. Messages suggest behavioral changes, provide positive feedback, and 
allow patients to request additional assistance as needed. Randomized trials have found that text 
messaging is effective for short- and long-term abstinence. In a meta-analysis including two 
randomized trials of 1905 smokers, text messaging increased self-reported tobacco cessation at 
four to six week follow-up, compared to control (RR 2.2, 95% CI 1.8-2. 7). Whittaker , Borland, 
Bullen, et al, (2009). In a subsequent trial of 5800 smokers, those randomly assigned to text 
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Group therapy allows smokers to learn behavioral techniques among their peers, with the 
intent of providing mutual support among group members and it is nearly twice as efficacious as 
self-help programs (Stead, Lancaster, 2005). One year quit rates for persons who complete such 
programs are approximately 20 percent. Despite the efficacy of group therapy, only a minority of 
smokers are willing to attend them, citing the inconvenience. Group sessions typically include 
short didactic presentations about the quitting process, group interactions, exercises on self-
monitoring of one's smoking habit, some form of tapering method leading to a quit date, 
development of coping skills, and suggestions among members for relapse prevention. Group 
therapy allows patients to learn behavioral techniques from several participant perspectives while 
mutually supporting others attempting to quit (Stead, Lancaster, 2005). 
A noteworthy approach regarding smoking cessation in the primary care setting is that of 
Problem Solving and Skills Training where the smoker anticipating quitting should be 
encouraged to identify situations or activities that may increase the risk of smoking or relapse 
(Ussher, 2005). Examples include having smokers within the household or at the workplace, 
getting into stressful situations, and alcohol use. Once the "danger situations" have been 
identified, coping skills should be explored. The nature and time course of withdrawal should be 
described. Learning strategies (cognitive and behavioral) that will reduce negative moods may 
also be helpful. 
Strategies to enhance coping may include making lifestyle changes to reduce stress and 
improve quality of life (eg, starting an exercise program, learning relaxation techniques). In one 
randomized trial of 281 female smokers, vigorous exercise, used in conjunction with a cognitive-
behavioral smoking cessation program, enhanced short and long-term (up to one year) 
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abstinence, and delayed weight gain following smoking cessation (Marcus, Albrecht, King, et al., 
1999). Further investigation is required to clarify the potential role of exercise programs in 
promoting smoking cessation. 
The smoker should be encouraged by the practitioner to explore how to minimize the 
time spent in the company of smokers. When other smokers are in the home, the recent ex-
smoker could consider negotiating with household members not to smoke within the home or 
car. Lancaster T, Stead, (2002) concludes that the key to successful quitting is to equip the 
smoker with as much information as possible about what to expect during quit attempts. 
Supplementing information discussed during visits and on the telephone with self-help materials 
may serve both as a reinforcer and a time saving resource for the clinician. These materials 
include pamphlets or booklets and videos or audio tapes on smoking cessation, a hotline or help 
line, the internet, and support groups. Several medical centers now have patient resources or 
learning centers in which patients can access additional self-help materials (Lancaster, Stead, 
2002). 
A multidisciplinary approach has been researched and proven to be successful in the 
primary care setting. Zwar, Richmond, Halcomb, et al., (2010) completed a study in recognition 
of the chronic nature of tobacco dependence, where a multidisciplinary, team-based approach is 
used, which has been implemented with successful abstinence rates in observational studies. 
Utilizing other members of the care team, as well as making use of electronic systems to flag a 
patient's active smoking status, more conversations between patients and clinicians may occur 
during office visits as part of an overall strategy for a team approach to care. A study that looked 
at the impact of adding smoking-related vital sign questions to patients' electronic records found 
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that clinician-documented smoking cessation counseling rates were significantly increased 
(McCullough, Fisher, Goldstein, et al., 2009). Other studies have looked at non-clinician-based 
systems approaches to enhancing smoking cessation rates. For instance, one study found that 
incorporating a smoking cessation template into electronic notes and providing patient education 
during referrals to clinical pharmacists was an effective method to enhance smoking cessation 
rates (Ragucci, Shrader, 2009). 
Relapse after an attempt at smoking cessation is common. Most smokers make many 
attempts to quit before they achieve success. The availability of over-the-counter smoking 
cessation aides means that clinicians will see an increasing number of smokers who have already 
made multiple unsuccessful attempts to quit. These patients may be highly dependent upon 
nicotine, making it even more imperative that the clinician be knowledgeable about available 
treatment options and resources. There is relatively little evidence that specific interventions 
prevent relapse after smoking cessation, however, it is reasonable to try simple interventions that 
promote abstinence (Hajek, Stead, West, et al., 2013). The clinician should take every 
opportunity to encourage and congratulate the patient on quitting. The benefits of smoking 
cessation can be highlighted by simply asking how their lives have changed since they stopped 
smoking. An equally important step is to address any problems encountered as a result of 
abstinence (e.g. weight gain, depression, or change in relationships with other smoking friends or 
relatives). Fiore, Jaen, Baker, et al., (2008), studied and found that most smokers make many 
attempts to quit before they achieve success. Smokers should be made aware of this when they 
are attempting to quit, and when they have relapsed after a quit attempt. The clinician should 
assess for non-adherence or improper use of cessation aides when a patient who has quit 
PRACTICE CHANGE 44 
smoking relapses. Determining the patient's insight into the possible reasons why the attempt 
failed and explore solutions for the next quit attempt would be an appropriate next step. Screen 
and treat comorbid conditions that may affect relapse such as depression and also chemical 
dependency other than nicotine. Referral was another approach for relapse prevention and 
intervention to a subspecialty clinic or smoking cessation program for the smoker who is heavily 
dependent upon nicotine or has had multiple unsuccessful attempts. Different types of providers 
(physicians, nurses, psychologists, dentists) may improve smoking cessation rates; involving 
multiple types of providers may enhance success. Intensive individual and group counseling also 
is often effective (Fiore, Jaen, Baker, et al., 2008). 
McCullough, Fisher, Goldstein, Kramer, Ripley-Moffitt (2009) studied strategies to 
improve smoking cessation counseling in clinical settings which are critical to supporting 
smokers' attempts to quit. This study evaluated the impact of adding two smoking-related vital 
sign questions in an electronic medical records system on identification, assessment, and 
counseling for patients who smoke: "Current smoker?" and "Plan to quit?" The method utilized 
baseline data of no tobacco use assessment, and data after intervention (assessment of tobacco 
use}, which were collected through record review of 899 randomly selected patient visits across 
3 outpatient clinics. The results revealed from before to after intervention, identification of 
smokers increased 18% (from 71 % to 84%; P<.001 ), and assessment for a plan to quit increased 
100% (from 25.5% to 51 %; P<.005). Among all smokers, cessation counseling increased 26% 
(from 23.6% to 29.8%; P=.41). Significantly more smokers who received the assessment for a 
plan to quit received cessation counseling ( 46% vs. 14%, P<.00 l ). Regression analysis showed 
that patients receiving an assessment for plan to quit were 80% more likely to receive cessation 
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counseling (OR 0.209;95% CI, 0.095-0.456). The authors concluded that Physician-documented 
counseling rates were significantly higher when patients are asked about smoking and assessed 
for a plan to quit. Two questions that ask about smoking status and assess plans to quit may 
provide prompts to increase the likelihood that patients who smoke receive cessation counseling 
(McCullough, Fisher, Goldstein, Kramer, Ripley-Moffitt (2009). 
Pharmacotherapy 
Pharmacotherapy for smoking cessation aims to reduce the symptoms of nicotine 
withdrawal, thereby making it easier for a smoker to stop the habitual use of cigarettes. The main 
medications that have demonstrated efficacy as smoking cessation aids include nicotine 
replacement, bupropion, and varenicline. Smoking cessation pharmacotherapy should be offered 
to all smokers making a quit attempt, unless medically contraindicated (Fiore, Jaen, Baker, et al., 
2008). Since tobacco use is both a learned behavior and a physical addiction to nicotine for the 
majority of smokers, the combination of counseling and pharmacologic therapies can produce 
higher quit rates than either one alone (Rigotti, 2002). Smoking cessation clinical guidelines 
from the United States Public Health Service consider seven drugs to be first-line agents for 
tobacco cessation (Fiore, Jaen, Baker, et al., 2008). The Transdermal nicotine patch, Nicotine 
gum, Nicotine lozenge, Nicotine inhaler, Nicotine nasal spray, Bupropion, and Varenicline are 
the recommended guidelines and available in some countries are a nicotine mouth spray and 
sublingual tablets. 
The goal of nicotine replacement therapy (NR T) is to provide nicotine to a smoker 
without using tobacco, thereby relieving nicotine withdrawal symptoms as the smoker breaks the 
behavior of cigarette smoking. The use ofNRT in place of cigarettes avoids exposure to carbon 
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monoxide that reduces oxygen delivery, to oxidant gases that are atherogenic, and to tars that are 
carcinogenic. 
Nicotine Replacement Products 
Nicotine replacement products differ in their pharmacokinetics and delivery of nicotine to 
the circulation (Rigotti, 2002). Nicotine is absorbed transdermally with the nicotine patch, 
through the nasal mucosa by the nasal spray, or through the oral mucosa with the nicotine 
chewing gum, mouth spray, lozenge, sublingual tablet, or inhaler. No product delivers nicotine as 
rapidly as cigarette smoking, a factor that contributes specifically to the dependence-producing 
properties of cigarettes. The patch has a long-acting, slow-onset pattern of nicotine delivery, 
producing relatively constant withdrawal relief over 24 hours, but requiring several hours to 
reach peak levels. Compliance with the patch is high, but the user has no control of nicotine dose 
to respond to nicotine cravings and withdrawal symptoms during the day. By contrast, the nasal 
spray and oral forms of nicotine replacement (gum, lozenge, and inhaler) share a short-acting but 
rapid-onset pattern of nicotine delivery that allows the user flexibility to respond to acute 
cravings or withdrawal symptoms. However, the nasal and oral forms require repeated use 
throughout the day, lead to more variable nicotine levels, and require more instruction for correct 
use. Currently, there are three NRT products which are available in the US without a prescription 
(patch, lozenge, and gum). Two (nasal spray and oral inhaler) are available by prescription only. 
Electronic cigarettes 
Electronic cigarettes ( e-cigarettes) use an electronic delivery system that aerosolizes 
nicotine. Many e-cigarette products are available that vary in their consistency and nicotine 
delivery. Several have been studied for smoking cessation, but data supporting their efficacy in 
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this context are lacking. Electronic cigarettes (e-cigarettes) use an electronic delivery system 
that aerosolizes nicotine, producing a vapor similar to cigarettes but containing fewer traditional 
toxins (Yamin, Bitton, 2010). E-cigarette devices are composed of three parts: a plastic tube, an 
electronic heating element, and a liquid nicotine cartridge. The user presses a button that 
simultaneously releases a puff of vaporized nicotine while illuminating the device tip (that 
simulates the lit end of a cigarette). E-cigarettes do reduce the desire to smoke traditional 
cigarettes and have been prescribed by clinicians to aid in smoking cessation (Bullen C, 
McRobbie, Thomley, et al., 2010). 
E-cigarettes are being increasingly used by the general population, mostly as a result of 
internet advertising and sales (Etter, 2010). There are many available products that vary greatly 
in consistency, in nicotine delivery, and in other additives that may have their own toxicity. A 
2009 US Food and Drug Administration (FDA) report one-cigarettes found trace amounts of the 
harmful solvent diethylene glycol as well as nitrosamines which are known carcinogens. This 
report also found nicotine in 'light' e-cigarettes that were labeled as being nicotine-free. The 
FDA has not approved the use of any e-cigarettes given safety concerns, particularly related to 
use in adolescents and potential toxic ingestion among children 
( fda.gov /Safety/MedWatch/Safetylnformation/Safety AlertsforHumanMedicalProducts/ucm 1733 
27.htm). Data from one pilot study reports common adverse effects of e-cigarettes as dry cough 
and irritation in the oropharynx (Polosa, Caponnetto, Morjaria,, et al., 2011 ). Whether initial 
recreational use of e-cigarettes leads to smoking of conventional cigarettes is unknown. 
Despite their increasing popularity, little is known about e-cigarette use, potential for 
addiction, or long-term health effects from smoking and second-hand smoke. Whether e-
PRACTICE CHANGE 48 
cigarettes can help smokers to quit or permanently stop using tobacco products is uncertain 
( fda.gov/Safety/MedWatch/Safetylnformation/Safety AlertsforH umanMedicalProducts/ucm 173 3 
27 2010). A randomized trial that compared e-cigarettes with nicotine patches among smokers 
who wanted to quit found no significant difference in the cessation rates produced by the two 
treatment arms, although the study was underpowered and could have missed important 
differences in the effectiveness of e-cigarettes compared with patches (Bullen, Howe, Laugesen, 
et al.(2013). While this trial suggests that e-cigarettes might have the potential to be smoking 
cessation aids, further studies will be required to establish the efficacy and safety of e-cigarettes 
for cessation. 
Relapse Prevention 
Most relapses occur soon after a person quits smoking, yet some people relapse months 
or even years after the quit date. All clinicians should work to prevent relapse. Relapse 
prevention programs can take the form of either minimal (brief) or more intensive programs. 
There is relatively little evidence that specific interventions prevent relapse after smoking 
cessation (Hajek, Stead, West, et al., 2013), however, it is reasonable to try simple interventions 
that promote abstinence. The authors conducted randomized or quasi-randomized controlled 
trials of relapse prevention interventions with a minimum follow-up of six months. They 
included smokers who quit on their own, were undergoing enforced abstinence, or were 
participating in treatment programs. They included trials that compared relapse prevention 
interventions with a no intervention control, or compared a cessation programs with additional 
relapse prevention components with a cessation programs alone. 
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The clinician should take every opportunity to encourage and congratulate the patient on 
quitting. The benefits of smoking cessation can be highlighted by simply asking how their lives 
have changed since they stopped smoking. An equally important step is to address any problems 
encountered as a result of abstinence ( eg, weight gain, depression, or change in relationships 
with other smoking friends or relatives). Relapse prevention should be part of every encounter 
with a patient who has quit recently. (Hajek, Stead, West, et al., 2013). Most smokers make 
many attempts to quit before they achieve success. Smokers should be made aware of this when 
they are attempting to quit, and when they have relapsed after a quit attempt. The clinician 
should assess for non-adherence or improper use of cessation aides when a patient who has quit 
smoking relapses. Determine the patient's insight into the possible reasons why the attempt failed 
and explore solutions for the next quit attempt. Screen and treat comorbid conditions that may 
affect relapse such as depression and/or chemical dependency other than nicotine (Hajek, Stead, 
West, et al., 2013). 
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CHAPTER 3 - PROJECT DESCRIPTION 
Introduction 
The primary care setting is an ideal location for the promotion of smoking cessation 
through counseling and pharmacological interventions. Smoking cessation options should be 
offered by PCPs at each office visit. Meta-analyses of clinical trials have found that behavioral 
counseling and pharmacotherapy with nicotine replacement each has strong evidence of efficacy 
for smoking cessation, and that the combination of the two methods produces the best results 
(Stead, Lancaster, 2012). The United States Public Health Service clinical practice guide 
"Treating Tobacco Use and Dependence: 2008 Update" states that all health professionals need 
to more effectively engage all patients who smoke (Fiore, et al., 2008). This information is of 
importance due to a study of 1,898 patients who reported that they had been asked about tobacco 
use or were advised to quit during their latest visit had a 10% greater satisfaction rating and 5% 
less dissatisfaction than those who did not report such discussions (Fiore, et al., 2008). 
Telephone QuitLine counseling has been effective in the past with diverse populations 
and has had a broad reach. Therefore, both clinicians and health care delivery systems should 
continue to ensure patient access to QuitLines and promote QuitLine use. Recent studies, (figure 
B), however have shown that the Tennessee QuitLine calls has been on the decline and from a 
personal perspective, a large percentage of patients have not called or gained advice to quit 
tobacco after getting a QuitLine card or brochure. 
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McCullough, et al., (2009) studied strategies to improve smoking cessation counseling in 
clinical settings which are critical to supporting smokers' attempts to quit. This study evaluated 
the impact of adding two smoking-related vital sign questions in an electronic medical records 
system on identification, assessment, and counseling for patients who smoke: "Current smoker?" 
and "Plan to quit?"(McCullough, et al., 2009). 
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Practice Change 
The goal of the practice change is to provide improved patient care by increasing providers' 
adherence to the recommendations of a clinical practice guideline for the assessment and 
treatment of smoking cessation in the primary care setting. 
Rosswurm and Larrabee's model proposed that six phases are involved in a practice change. 
• Assessing the need for a practice change. The Southeast Regional Health Departments 
currently does a smoking assessment survey on new and annual patients. The data 
collected unfortunately becomes 'invisible' to the practitioners in terms of patients' 
desire to quit or their history of smoking cessation attempts. This information is based 
solely on observation for approximately one year by the project leader. Formal data 
collection or research has not been done to validate the findings however, clinical 
experience has given reasonable support for the need for this practice change. The 
QuitLine is also used as an intervention where brochures and cards are provided to the 
patients, but on return visits based on the project leader's observation, the QuitLine 
approach has not proven to be an effective intervention. Patients have expressed that 
they "just don't call", "don't want to call back" after the initial attempt, or they are "not 
motivated to call". An official primary meeting is generally held quarterly and an 
assessment of the current practice of addressing smoking cessation among the providers 
would be discussed and identification of current and experienced problems would be 
discussed. 
• Linking the problem with nursing interventions and patient care outcomes. According to 
the recent tobacco use update guidelines (Fiore, 2008), increasing evidence has shown 
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that screening and assessment practices such as expanding vital signs to include tobacco-
use status, or other reminder systems to ask about smoking significantly increases the rate 
of clinician intervention. Presently, the three primary care sites do not include patient's 
tobacco use status on the progress notes as a component of the vital signs. 
For smokers who are not ready to quit, the clinician's role is to assess the patient's 
perspective (of the risks and benefits of continuing to smoke) in order to help the smoker 
to begin to think about quitting. Most smokers have a general desire to stop smoking, but 
may not be ready to take specific action to quit, for a variety of reasons. Asking a smoker 
what he or she likes and does not like about smoking is a way to start. A personalized 
message concerning a smoking-related health problem may motivate some patients into 
action. Clinicians can use motivational interviewing techniques to explore a smoker's 
feelings, beliefs, ideas, and values regarding tobacco use. The model of "5 Rs" 
(Relevance, Risks, Rewards, Roadblocks, Repetition) is helpful to motivate smokers who 
are not ready to quit (Appendix B). 
• Synthesizing the best evidence. Based on current research, providers should note that 
simply giving standardized self-help materials (QuitLine) to a patient may have little 
positive effect on his or her success. Every smoker should be asked if he or she is willing 
to quit. If the patient wants to attempt to quit, the clinician should guide the patient in 
selecting an appropriate treatment. It is important to understand the stages of motivation 
utilizing the TIM, to change behavior in order to plan an effective intervention. Most 
smokers (80%) fall into one of two of the change categories: pre-contemplation or 
contemplation. The two distinct groups of individuals need very different approaches to 
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smoking cessation. Patients who fall into the pre-contemplation stage are not convinced 
the health hazards associated with smoking apply directly to them. They may not want to 
make a change in smoking as a health behavior, or they may express doubts about their 
ability to successfully make a change. The goal for these patients are to instill a sense of 
doubt about the desire to continue smoking, raise an awareness of the health hazards of 
smoking and their direct effect on the patient's health and well-being and communicate 
the benefits of quitting, exploring the positive perceptions the patient has about smoking 
may help overcome the resistance commonly seen in this stage of the change process. 
Patients in the contemplation stage seek out information about the quit attempt but are 
unwilling to make a commitment to quit or express self-doubt about their ability to 
successfully quit. Identifying the positive and negative aspects of continuing to smoke 
and emphasizing the negative consequences of continuing to smoke will help the 
contemplator resolve ambivalence toward continuing to smoke. 
The use of an algorithm has proven to be an effective tool which integrates the 
recommendations of the major guidelines and meta-analyses and provides rationales for 
its treatment decisions. An algorithm suggests a brief assessment followed by use of one 
to two medications and counseling in most smokers. Because all treatments appear 
equally effective and have few adverse events, the algorithm suggests clinicians inform 
smokers of the pros and cons of the different treatments, and recommend use of one or 
more of each (Bader, McDonald, Selby. 2009). The proposition of having an algorithm 
for providers to employ during encounters will also be an entity of the proposal for the 
practice change at the primary care sites. 
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• Designing the practice change. Based on peer reviewed, current evidence based 
literature, the proposal would entail three entities to supplement, enhance and intensify 
the already established protocol. The first would be to incorporate the TTM on stages of 
change and respond appropriately based on their motivation. An added section with the 
five stages of change from the TTM would be on the progress notes to be addressed with 
each encounter. Patients would continue to be provided with the Tennessee Quit-line 
information. The second would be to include the patients' smoking status as a part of the 
'vital sign' section which could be determined by the certified nurse's assistances 
(CAN's). The third proposition would be to have an algorithm as a guide for the 
necessary approaches for smoking cessation in the primary care setting. This proposal 
would then be given to the regional medical director to review and then present same to 
the regional director for the Southeast Region of Health Department for review by the 
board of directors. 
• Implement and evaluate change in practice. This practice change project would involve 
interacting with the Tennessee Department of Health (TDH) patients, their surveys, and 
chart reviews at the local health departments. The requirements would entail an 
application to the TDH IRB which would need a review prior to submission to the TDH 
IRB by the Regional Director and the Medical Director of Community Health Services. 
A development of a two page executive summary of the project with the research query, 
methods, eligible population that would be researched and why, data analysis plan, and 
the potential conclusions and knowledge that will be gained by the project. After 
approval of the overall plan, then a pilot study would be done for approximately six 
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months while evaluating the process and outcomes. A decision would then be 
determined to adapt, adopt or reject the practice change. 
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• Integrating and maintaining the change in practice. Upon acceptance of the proposal, a 
pilot study would be in order for approximately six months to one year to determine the 
efficacy of the proposed change and on the annual evaluations of the smoking cessation 
surveys by the epidemiologist, determining statistical significance would be deemed 
positive or negative. Communicating the results and the recommended change of the 
pilot study at the quarterly primary care meeting would be done to ensure appropriate 
integration into the standards of practice. 
Proposal 
When providers sees a patient for the first they should first assess the patient's tobacco 
use, the desire to stop smoking, and the history of previous quit attempts, including methods used 
and their effectiveness (West, 2004). A smoker's dependence on nicotine can be estimated from 
the duration of smoking history, the number of cigarettes smoked daily, and how soon after 
waking up the smoker has his or her first morning cigarette. More dependent smokers have 
smoked for many years, smoke more cigarettes daily, and smoke within the first 30 minutes of 
awakening. The smoker's degree of nicotine dependence predicts the difficulty that he or she will 
have in quitting and the intensity of treatment likely to be required (West, 2004). 
Two strategies studied to improve smoking cessation counseling in the clinical setting 
involves the inclusion of smoking related vital sign questions inquiring of the current tobacco 
usage and determining the current stage of change. McCullough, et al., (2009), concluded that 
this approach proved to be beneficial (Appendix F). 
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The use of an algorithm in the primary care setting has proven to be beneficial by 
providing a step-by-step procedure for health care practitioners to initiate a smoking cessation 
protocol into practice. It also serves as a concise, evidence-based resource that can be used by 
providers during a visit in a timely manner (Jones, 2014). After gaining consent from the 
publishers from two articles, an algorithm was developed after adapting, and pertained directly to 
the population at the Southeast Region Health Departments (Appendix D-a, Appendix D-b). 
Cost is an important financial concern to the Southeast Region Health Departments and 
the selection of projects that may contribute most to the attainment of its objectives, given 
resource constraints, is crucial and fundamental. The three proposed components may be a cost 
benefit in the future. The projected cost on acceptance of this proposal may entail obtaining 
additional resources from the CDC's publication department regarding handouts or brochures for 
encouraging and maintaining smoking cessation in addition to the already established QuitLine. 
The algorithm suggests distributing patient centered information depending on the stage of 
change they are currently experiencing. UpToDate® (UTD) is an already established and 
consumed computer access to the providers which synthesizes the most recent medical 
information into evidence-based practical recommendations clinicians trust to make the right 
point-of-care decisions. With appropriate terminology in the search engine, UTD offers two 
types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient 
education pieces are written in plain language, at the 5th t<;> 6th grade reading level, and they 
answer the four or five key questions a patient might have about a given condition. These articles 
are best for patients who want a general overview and who prefer short, easy-to-read materials. 
Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. 
PRACTICE CHANGE 58 
These articles are written at the 10th to 12th grade reading level and are best for patients who 
want in-depth information and are comfortable with some medical jargon. 
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CHAPTER FOUR: EVALUATION PROCESS 
Introduction to the Evaluation Process 
On approval of acceptance of the proposal, a six month pilot study of the two additional 
components of the vital signs and the addition of the TTM's stages of change will be utilized by 
the six primary care providers in the various counties of East Tennessee. An evaluation survey 
of the positive or negative effects of the proposed algorithm will then be distributed to each of 
the providers for a discussion at the following primary care meeting at the Southeast Regional 
Office in Chattanooga, Tennessee. 
CDC Framework for Program Evaluation 
The Centers for Disease Control and Prevention (CDC) Framework for Program 
Evaluation in Public Health provides guidance and structure to aid in the development of a 
comprehensive evaluation design that meets the evaluation standards set by the Joint Committee 
on Standards for Educational Evaluation and ensures the evaluation produces relevant, useful 
information (Centers for Disease Control and Prevention, 1999; Joint Committee on Standards 
for Educational Evaluation, 2010). The framework consists of six steps: (a) engaging 
stakeholders, (b) describing the program, ( c) focusing the evaluation design, ( d) gathering 
credible evidence ( e) justifying the conclusions, and ( t) ensuring utilization and sharing lessons 
learned (Figure 3). 
PRACTICE CHANGE 
Steps 
Engage 
~ Stakehold"'' ~ 
Ensure use and share 
lessons learned 
Standards 
Describe 
the program 
( Utility Feaslblllty Propriety 
Accuracy 
) 
Focus the 
evaluation design 
~Gathere<edible/ 
evidence 
Justify 
conclusions 
Figure 3. The CDC Program Evaluation Framework cdc.gov/eval/framework/index.htm 
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The steps are essential, interdependent, and iterative, but allow the flexibility to tailor an 
evaluation based on the program's context and the purpose of the evaluation. The underlying 
logic of the Evaluation Framework is that good evaluation does not merely gather accurate 
evidence and draw valid conclusions, but produces results that are used to make a difference. 
Step 1: Stakeholder Engagement 
Program evaluation is one of ten essential public health services and a critical 
organizational practice in public health. According to CDC (2011 ), the first step in this process 
is engaging stakeholders. Stakeholders are people or organizations invested in the program and 
interested in the results of the evaluation. Representing their needs and interests throughout the 
process is fundamental to good program evaluation. The participation of stakeholders ensures 
their perspectives and values are understood, and increases buy-in to the findings and changes 
made as part of the process (Centers for Disease Control and Prevention, 1999; Minkler, 2005; 
Patton, 2008). 
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The evaluation process will include several stakeholders of the Southeast Regional 
Health Departments including, but not limited to the Regional Director, Medical Director of 
Community Health Services, Director of Quality Improvement, epidemiologist, providers, staff, 
and patients as active participants, with each participant providing input from their unique 
knowledge and experiences. Program evaluation involvement can be empowering and allow 
each voice to be heard however, it may require a commitment of time and effort that may be hard 
for some individuals and not feasible for others within the time constraints of the proposal. 
Patients input will be particularly important because their needs, attitudes, and goals may differ 
significantly from individuals from the other stakeholders and their perspectives may differ from 
the health care providers. Stakeholder involvement would be maintained throughout the entire 
practice change protocol evaluation process. 
Step 2: Program Description 
The second step of the CDC framework is an accurate, comprehensive description of the 
program. A comprehensive program description clarifies all the components and intended 
outcomes of the program, thus helping the project manager focus the evaluation on the most 
central and important questions. 
A comprehensive program description includes the following components: 
Need. The public health problem that will be addressed with this practice change is the 
seemingly lack of smoking cessation among the primary care patients in the Southeast Regional 
Health Department ages 19-64 years in the past 18 months. 
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Targets. To ensure progress with this public health problem, the attention of the Office of 
Quality Improvement and the Medical Director of Community Health Services needs to be 
aroused. 
Outcomes. The ultimate outcome would be a significant reduction of tobacco use by 
incorporating the proposed additional vital signs, the algorithm, and the distribution of pertinent 
brochures based on the patient's stage of change. Currently, only one intervention, QuitLine 
brochures, is distributed to the patients with limited information to address TTM stages of 
change. 
Activities. During the work up of patients, CNA's will be able to ask questions pertaining to 
tobacco use and determine their stage of change. The provider will assess their smoking status 
and will then distribute the appropriate handout or recommend medications for patients willing 
to quit or reduce their tobacco usage. 
Outputs. The tangible capacities that will be produced by this program's activities would be 
attaining the ultimate goal of the Tennessee Department of Health Mission: To protect, promote, 
and improve the health and prosperity of people in Tennessee. 
Resources and Inputs. In order for these activities to be mounted successfully would include 
brief training of the CNA's during the assessment of vital signs, informing the other primary care 
sites and their providers of the change to the progress notes, sharing the concise algorithm and 
various treatments for medication use. Regarding cost, these three components of the proposal 
would eventually prove to be perhaps a cost benefit in terms of a decrease in tobacco usage and 
consequently a reduction in tobacco related illnesses and diseases due to the easy accessibility to 
the providers. The projected miniscule cost on acceptance of this proposal may entail obtaining 
PRACTICE CHANGE 63 
additional resources from the CDC's publication department regarding handouts or brochures for 
encouraging and maintaining smoking cessation in addition to the QuitLine. Regarding 
documentation forms, a master copy is located on the hard drive which is easily amended by the 
appropriate staff which are generally printed weekly on an as needed basis. 
Stage of Development. This program is in its planning stage. After approval of the program by 
the appropriate committee, then it would progress to the implementation stage. 
Context. The factors and trends in the larger environment which may influence this program's 
success or failure include lack of patient's motivation to quit tobacco use, providers negligence 
of addressing tobacco usage at each office visit, and close involvement of the Medical Director. 
Step 3: Focus the Evaluation Design 
According to CDC (2011 }, the design is to be determined by the purpose and aims of 
evaluation, the intended uses of the findings by the key stakeholders or decision- makers in a 
program, and resources available to conduct the evaluation. The design for this proposal for a 
practice change would look retrospectively at the quit rate prior and the quit rate after 
implementation of the change. After obtaining IRB approval and completing the necessary 
required documents, access to the electronic data base and review of charts for the past 18 
months would be compared to at least six months' worth of implementation of the proposal for 
the practice change. 
Step 4: Gather Credible Evidence 
Evidence gathering in a program evaluation is analogous to data collection in research 
studies. The data gathered must be credible and relevant for answering the evaluation questions. 
The use of mixed methods of data collection with qualitative and quantitative data is 
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recommended to increase the richness and accuracy of the data (Johnson & Onwuegbuzie, 2004; 
malterud, 200 l ). Data sources are determined by the research query and may include client 
records individual interviews of participants, staff, and key informants, program policies and 
procedure manuals. 
The recommended combination of qualitative and quantitative data will be used in the 
evaluation of the proposal for smoking cessation in the practice change. 
Step 5: Conclusions 
This step encompasses analyzing the evidence, making claims about the program based 
on the analysis, and justifying the claims by comparing the evidence against stakeholders' 
values. In the CDC program evaluation framework, conclusions are justified through synthesis 
of the findings obtained from data analysis interpreted within the conceptual framework and 
context of the program, and the values of the stakeholders (Baker, Davis, Gallerani, Sanchez, & 
Viadro, 2000). 
This interpretation and judgment concerning the practice change will be performed in 
collaboration with the key stakeholders. The data analysis results will be presented at the 
quarterly primary care meetings with the Medical Director, the primary care providers, the 
registered nurses and some ancillary staff. 
Step 6: Evaluation Use and Dissemination 
The final step in the CDC program evaluation framework is to ensure use of the 
evaluation findings and lessons learned. To accomplish this step, plans should be made at the 
very beginning of the program evaluation process. The design must be tailored to achieve the 
uses intended by the primary stakeholders. The evaluation findings must be credible and any 
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recommendations made must be feasible to increase the likelihood of their use. The primary 
uses of the proposal evaluation information will be the Regional Medical Director and the 
Medical Director of Community Health Services. As directors within public health system, these 
individuals will anticipate that the program evaluation results would reveal areas of strength and 
weaknesses in the program and provide insight into the clients' experiences. This information 
will provide insight into needed refinements and methods of improving the program. Active 
participation of these stakeholders in the program evaluation process will perhaps increase the 
likelihood that they will accept and use the findings. Feedback to and from the users at each step 
of the evaluation process by email and periodic meetings will maintain involvement and ensure 
the evaluation continue to be focused, relevant, and useful (CDC, 2005). 
The ultimate purpose of a program evaluation is to use the information to improve 
specific programs. The purpose initially identified early in the evaluation process should guide 
the use of the evaluation results. The evaluation results can be used to demonstrate the 
effectiveness of the program, identify ways to improve the current program, modify program 
planning, and demonstrate accountability. Dissemination involves communicating evaluation 
procedures or lessons learned to relevant audiences in a timely, unbiased, and consistent manner. 
Regardless of how communications are structured, the goal for dissemination is to achieve full 
disclosure and impartial reporting (CDC, 2011). 
Evaluation Method 
The evaluation method proposed for this practice change would consist of both 
qualitative and quantitative methods. Identifying how many cigarettes are smoked and how 
often, daily or weekly, would satisfy the quantitative method. Identifying the positive use of the 
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information provided and what it meant from the patient's perspective would satisfy the 
qualitative method. Quite often qualitative data can provide contextual meaning to the 
quantitative data in a project that uses both (Zaccagnini, & White, 2011 ). Tools that may 
possibly be utilized would include interviews, written questions and surveys, health factors, and 
chart reviews. 
According to CDC (2011 }, a logic model is a systematic and visual way to present the 
perceived relationships among the resources one has to operate the program, the activities ones 
plans to do, and the changes or results one hopes to achieve. It is a picture of how the project 
developer believes the program will work and uses a series of diagrams to indicate how parts of 
the program are linked together or sequenced. The logic model depicted in Figure 4, clearly 
summarizes all the entities specific for this practice change proposal. 
Inputs - These are materials that the organization or program takes in and then processes 
to produce the results desired by the program. 
Activities These are used by the program to manipulate and arrange items to produce 
the results desired by the program. 
Outputs Outputs are usually the tangible results of the major processes in the 
organization. They are usually accounted for by their number, and in this example, the 
number of calls to the QuitLine or use of prescribed medication. 
Outcomes -These are the results of the impacts on those people who may have benefitted 
from this program. Outcomes are usually specified in terms of: a) learning, including 
enhancements to knowledge, understanding, perceptions, attitudes, and behaviors 
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Promoting Smoking Cessation Among Young People and Adults 
Logic model for promoting smoking cessation among young people and adults 
£ ......... al 
amlJon ....... ill 
._.,. Klaal*. 
---~ 
....................... 
Figure 4: Logic Model 
http://www.cdc.gov/tobacco/tobacco control programs/surveillance evaluation/evaluation manual/pdfs/ 
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Data Analysis 
Content analysis will be used to analyze the qualitative data obtained from interviews, 
focus groups, and comments written on participant surveys. The content analysis would be 
determined by the specific concerns for the practice change, using a simple, systematic, 
verifiable process. Each interview, focus group discussion, and participant survey comment will 
be transcribed and each line numbered. Possible descriptive statistics of the data may include 
frequencies, means and summary statistics. To identify any significant changes in the tobacco 
survey and patients' smoking cessation status, possible pre and post intervention measures would 
be analyzed with the paired t test. The level of significance for each analysis would be 
designated as less than 0.05. Data would be analyzed by using the Statistical Package for Social 
Sciences (SPSS) Graduate Pack 22.0, student version with the assistance of the epidemiologist 
and a statistician. 
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CHAPTER 5: RECOMMENDATIONS 
The primary care setting is the ultimate location to promote smoking cessation through 
counseling and pharmacological aids. Effective smoking cessation options should be promoted 
by primary care providers at every opportunity and may be reimbursed through private and 
public health care programs for smoking cessation counseling during a regular office visit. 
Assessing tobacco use status during healthcare visits increases the likelihood of smoking-
related discussions between patients and clinicians, as well as increases smoking cessation rates. 
The clinician should assess the patient's cigarette use, the desire to stop smoking, and the history 
of previous attempts to quit, including methods used and their effectiveness. The importance of 
specific advice to quit smoking, regardless of the patient's motivational status, should be 
underscored. Every patient who smokes should be urged to quit in a clear, strong, and 
personalized manner. Not every patient counseled on smoking cessation will be prepared to 
consider quitting. 
For smokers who are not ready to quit, the clinician's role is to assess the patient's 
perspective of the risks and benefits of continuing to smoke, in order to help the smoker to begin 
to think about quitting. Clinicians should also use motivational interviewing techniques to 
explore a smoker's feelings, beliefs, ideas, and values regarding tobacco use. The USPHS 
guideline has proposed the model of "5 Rs" (Relevance, Risks, Rewards, Roadblocks, 
Repetition) in promoting motivation in patients who are unwilling to quit. 
The hope and goal of this practice change protocol was to provide improved patient care 
by increasing providers' adherence to the recommendations of a clinical practice guideline for 
the assessment and treatment of smoking cessation in the primary care setting. The project 
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manager has determined that there is sufficient evidence to warrant initiating the process of a 
practice change. Internal data, though available to TDH staff only, has evidenced the need for a 
change regarding the assessment and implementation for smoking cessation achievement. A 
major barrier that was encountered for this practice change implementation was initiating the 
IRB process, which was quite involved, and required a minimum of twelve weeks before a 
review by the IRB committee (Appendix H). The field of smoking cessation treatment is rapidly 
expanding. Randomized controlled trials of commonly used smoking cessation techniques, 
including individual, group, and telephone counseling, have demonstrated success in helping 
smokers quit and maintaining long-term abstinence. In addition, rapid expansion in 
pharmacotherapy has resulted in multiple drug agents and systems of delivery directed at treating 
the biologic basis of tobacco addiction. The project manager and the medical director discussed 
at length the possibility of presenting the above mentioned protocol with extensive evidence 
based literature to confirm the need of a change. 
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Appendix - A Tobacco Survey 
Patient Tobacco Survey 
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Appendix B 
F"sve "R's" to motivate smokers unwiling to quit 
Intervention Technique 
Relevance Encourage the patient to indicate why quitting is personally relevant, being as specific 
as possible. Motivational information has the greatest impact if it is relevant to a 
patient's disease status or risk, family or social situation Ceo. having children in the 
home), health concerns, age, gender, and other important patient characteristics Ceo. 
prior quitting experience, personal barriers to cessation). 
Risks Ask the patient to identify potential negative consequences of tobacco use. The clinician 
may suggest and highlight those that seem most relevant to the patient. The clinician 
should emphasize that smoking low-tar/IOw-nicotine cigarettes or use of other forms of 
tobacco (eg, smokeless tobacco, cigars, and pipes) wiH not eliminate these risks. 
Examples of risks are: 
Acute risks - Shortness of breath, exacerbation of asthma, harm to pregnancy, impotence, 
infertility, and increased serum carbon monoxide. 
Long-term risks - Heart attacks and strokes, lung and other cancers (larynx, oral cavity, 
pharynx, esophagus, pancreas, bladder, cervix), chronic obstrudive pulmonary diseases 
(chronic bronchitis and emphysema), long-term disability, and need for extended care. 
Environmental risks - Increased risk of lung cancer and heart disease in spouses; higher rates 
of smoking in children of tobacco users; increased risk for low birth weight, Sudden Infant 
Death Syndrome, asthma, middle ear disease, and respiratory infections in children of 
smokers. 
Rewards Ask the patient to identify potential benefits of stopping tobacco use. The dinician may 
suggest and high~oht those that seem most relevant to the patient. 
Examples of rewards include: 
I Improved health 
I Food will taste better 
I lmpn>ved sense of smell Save money 
I Feel better about yourself 
I Home, car, ctothing, breath will smell better 
I can stop worrying about Quitting 
I Set a good example for and have healthier babies and children 
I Not worry about exposing others to smoke Feel better physically and perform better 1n physical activities 
I Reduced wrinkling/aging of skin 
Roadblocks Ask the patient to identify barriers or impediments to quitting and note elements of 
treatment (problemsolving, pharmacotherapy) that could address barriers. 
Typical barriers might include: 
Withdrawal symptoms 
I Fear of failure 
I 
Weight gain 
Lack of support 
I Depression 
Enjoyment of tobacco 
Repetition The motivational intervention should be repeated every time an unmotivated patient 
visits the clinic setting. Tobacco users who have faded in previous quit attempts should 
be told that most people make repeated quit attempts before they are successful. 
Adapted from: Fiore ,.,c, Jaen C, Bilker T, et al. Treating tobacco use and dependence: 2008 update. Clinical 
Practice Guideline. Rockville, ,.,D: US Department of Health and Human Services. Public Healt:h Service. 2008. 
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Appendix C 
Five "A's" for assessing for tobacco use and addressing smoking cessation 
Intervention Technique 
Ask ~t an officewide system that enSlles that, for every patient at every enc visit, tobacco-use status IS ~d and doclll1ellted. Repeated assessment is not 
necessaiy in the case of the arult who has never used tobacco or has not used tobacco for ~y years, and fur whom tllis infurmation IS clearly doclll1ellted in the medical 
record. 
Advise Strorefl ll'ge all tobacco users to quit in a clea.-, strong, personaized manner. 
Advice shoUd be: 
Clear • 'I tlri t is ~for yoo to QI.it smoblg now and I can ~ you. 'Ct.ttilo down whie yoo are ii 1s not ~· 
strong • ·As yru clrician, I need yoo to know that~ smob1g IS the most ~ thin9 yoo can do to proted YOU' health now and in tile h.tll'e. The dilic staff and I w• 
~you. 
P~naized • fie tobacco use to C\ll'ent health/hss, arwl/or its soda and economic costs, motivation level/readness to QI.it, arwl/or the inpad of tobacco use on ~en and 
others in the household 
Assess Determinie the patienrs w~ to ~t smoblg within the next 30 days: 
If tile patielt is wililg to make a QI.it att• at tlis tine, provide assistance. 
If tile patient wil p~ate in an intensive treatment. deliver such a treatment or refer to an intensive intervention. 
If tile patient dearly states he or she is 111wl1'1Q to make a QI.it att• at this tine, prolide a motivational intervention. 
If the patient is a meiOOer of a special population ( eo, adolescent, preonart smoker), prolide ad<itional irtormation speclic to tllat population. 
Assist Provide aid for the patient to ~t. These actions a.-e sunmarized in the acc~nying table. 
Arrange Sched.ie folow·14> contact, either in pe!50fl or by telephone. Folow·14> contact shoUd occlJ' soon after the ~t date, preferably dtlilg the first week. A second folow·14> 
contact is recommended within the first montll. Sc~ liJther folow·14> contacts as in<icated. 
C~b.iate success dtlilg each folow-141. If tobacco use has occlfTed, review ci'C1111Stances and elicit reconrnitrnent to total abstilence. Remind the patient that a lapse 
can be used as a leanWig experience. Identify problems aieady encoontered and antic~ate chalenges in the imledate fuhle. Assess iramacotherapy use and problems. 
Consider use or referral to more intensive treatment. 
Adapted from: Fiore MC, Jaen C, Baker T, et al. Treating tobacco use and dependence: 2008 update. Clinical Practice Guideline. Rockville, MD: US Department of Health and Human Services. Public 
Health Service. 2008. 
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Appendix D-1: Algorithm Permission 
e + "' 'I w https www.southern.edu owa ?ae=Item&a=Open&t=IP ote 
Rep~ Reply All Forward 'f' ~ 
: Smo 1 g Al~ ·1 m 
Joy Hamilton 
To: es o R r h 1, ht e e 
Tu~ ·1~ch 18 2014 6:44 PM 
Thanks Mr. Hughes. This information will be included in my proposal to the Medical Director of the Southeast Region. 
Joy Hamilton 
From: Hughes, John R [john.hughes@med.uvm.edu] 
Sent: Tuesday, March 18, 2014 8:06 AM 
To: Joy Hamilton 
SUbject: RE: Smoking Algorithm 
No need to ask permission 
From: Joy Hamilton [mailto:joyh@southern.edu] 
Sent: Monday, March 17, 2014 5:01 PM 
To: Hughes, John R 
SUbject: Smoking Algorithm 
Good Day Mr. Hughes, 
My name is Joy Hamilton and rm currently perusing my Doctor of Nurse Practitioner degree at Southern Adventist 
University. rm a primary care provider working at the Health Department in a rural community. My project involves a 
practice change regarding smoking cessation in primary care. 
My purpose for contacting you is to gain permission to include in a proposal for a practice change from "An Algorithm for 
Choosing Among Smoking Cessation Treatments" I have found the information concise and informative 
If this would be a possibility for me to include this algorithm in my proposal it would be greatly appreciated 
Thanking you in advance. 
Joy Hamilton APN-BC 
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Appendix D-2: Algorithm Permission 
t e ·• j https:, twww.southern.edu o a . ae=Item&a=O en&t=IP 1. 
Rep~ Reply All Forward l" • • ~ ~ )( ~ • @ 
:::>r oki sa 1 J 
Joy Hamilton 
To: ~ 1. 
Tuesd~ AP<l 08 2014 4 :l6 PM 
Hello, 
My name is Joy Hamilton and rm currently pursuing my Doctor of Nurse Practitioner degree at Southern Adventist 
UniVersity. rm a primary care provider working at the Health Department in a rural community. My project involves a 
practice change regarding smoking cessation in primary care. 
My purpose for contacting you is to gain permission to include in a proposal for a practice change the algorithm 
from "Tobacco Cessation Algorithm.doc". I have found the information concise and informative which would be 
appropriate in serving the underserved and uninsured population that we see here at the local Health Department 
If this would be a possibility for me to include this algorithm in my proposal it would be greatly appreciated 
Thanking you in advance 
Joy Hamilton. APN-BC 
From: Goldstein, Adam O.[adam_goldstein@med.unc.edu] 
Sent: Tuesday, April 08, 2014 7:14 PM 
To: Joy Hamilton 
Cc: Ripley-Moffitt, Carol 
subject: RE: Smoking Cessation Algorithm 
Yes- please ensure Carol that it is ours though. 
Ag 
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Appendix D-3: Algorithm Permission 
From: Joy Hamilton [mailto:joyh@southem.edu] 
Sent: Tuesday, April 08, 2014 7:18 PM 
To: Goldstein, Adam 0. 
SUbject: RE: Smoking Cessation Algorithm 
76 
Thanks for the permission, however rm not too sure who carol is. I am writing form Dunlap, Tennessee and called 
the number on the web site and spoke with Mark who gave me your contact information. 
To give the appropriate credit for the algorithm, who should I list? 
Thanks, 
Joy Hamilton 
: 51 0 I s 101 'I rn 
Goldstein, Adam 0. [adam_goldstein@med.unc.edu1 
To: 
Cc: caro e ff 1 e n' 
Tuesday Ap<i 08 2014 ~ 20 PM 
Carol is the Program Director of our Nicotine Dependence Program. I just want to be sure you are using the 
correct algorithm. She can approve tomorrow. 
Thanks! 
Ag 
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Algorithm D-4: Algorithm Permission 
Rep 
~E S 
Reply All Forward ~ • . ~ ~ 
o~ 1ng Cessation Ale n in 
Ripley-Moffitt, Carol [carol_ripley-moffitt@med.unc.ed ... 
To: dam 0. ,m_ e c.e 1uy ,,mu o 
• 'lou replied on 4/9/2014 9:34 AM. 
77 
Wednesda)I Apr 09 2014 S 37 ,1 
Joy, can you please send a copy of the algorithm and where you obtained it. If it is from a textbook, we may 
need to get publisher's permission. 
• •oy I lon11 1 
Wednesdoy O!I 2!ll4 kU 
There was no web site ... just that 'tobacco cessation algorithm.doc' listed and the algorithm was there with the UNC info on top. n was not 
connected to any web site. Only 2 pages. Did you access it and see the algorithm rm referring to? 
• Ripley-Moffitt, Carol [carol_ripley-moffitt@med.unc.edu] 
Can you send me a copy or the address of the website? 
This was at the bottom of the page. tobacco cessation algorithm.doc 
It's only a pdf with the UNC information on the top. 
Thanks 
Wednesday AP" 2!ll4 34 
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Appendix D-5: Algorithm Permission 
p n Pr https:, twww.southern.edu o a ae=Item&a= 0 eri .... t=IP 1. 01 
Rep~· Reply All Forward • q1iJ ~ 
Rt : r ok IOr Ale n h1 
Ripley-Moffitt, Carol [carol_ripley-moffitt@med.unc.ed ... 
To: 
09 2014 L26 PM 
• Vou replied on 4 '9. '20141·28 PM. 
Is there any way you can send me a copy, i.e. scan into a pdf or send as a document? 
This does not sound familiar to me and it may be from another UNC department. If I could see tne UNC 
information, as well as the algorithm that would help. 
How did you come across this? 
From: Joy Hamilton [mailto:joyh@southern.edu] 
Sent: Wednesday, April 09, 2014 12:13 PM 
To: Ripley-Moffitt, Carol 
Subject: RE: Smoking Cessation Algorithm 
There was no web site ... just that 'tobacco cessation algorithm.doc' listed and the algorithm was there with the UNC 
info on top. It was not connected to any web site. Only 2 pages. Did you access it and see the algorithm rm 
referring to? 
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Appendix D-6: Algorithm Permission 
t e e t https· twww.southern.edu O\ a .ae=ItemSla=.J en&t=IP 1. 
Reply Reply All Forward ,- ~ 
E Sr oki .:e at1on Ale r 
Joy Hamilton 
To: R >ff (car _ e - >f' e e 
From: Ripley-Moffitt, Carol [carol_ripley-moffitt«Pmed.unc.edu] 
Sent: Wednesday, April 09, 2014 1:45 PM 
To: Joy Hamilton 
subject: RE: Smoking Cessation Algorithm 
Wednesday Apr 09 2014 152 PM 
Ok, as I suspected, this is from UNC Internal Medicine and is quite old, 2007. In addition, it references 
materials to give to patients that may no longer be in print. I would recommend a more recent article and 
diagram such as: 
htto://ac.els-cdn.com/S074054nl3000342/l-s2.0-SQ74054721300Q342-main.odf? tid=3ea04c08-cOQe=lle3-
80e6-00000aacb362&acdnat=l397065496 79a2ce3cle308369494799lf764al5d9 
or you can certainly use the UNC model, and substitute titles for available educational materials 
Good luck on your project, and let me know if you have questions, 
Carol 
l 
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Appendix E: Proposal Acceptance - first phase 
Joy Hamilton [Joy.Hamilton@tn.gov] 
To: 
From: Allyson Cornell 
Sent: Wednesday, April 23, 2014 12:18 PM 
To: Joy Hamilton 
Subject: RE: Practice Change Proposal Revised 
Joy, 
80 
I think this is a great proposal. I know you put a lot of time and work into creating this, and I definitely think this 
could benefit our patients in their attempts to stop smoking. I will definitely forward this on to Dr. Beville, Medical 
Director of Community Health Services, for her review. I also think the information you have collected, regarding 
tobacco cessation, would be great to share at our next primary care meeting with all our primary care providers. 
Thank you so much, 
Dr.Cornell 
Allyson Cornell M.D. 
Regional Medical Director 
Tennessee Department of Health, Southeast Region 
540 Mccallie Avenue 
Suite 450 
Chattanooga, Tennessee 37402 
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Sequatchie County Health Department 
Tobacco Cessation Algorithm 
No 
No action. 
Document in progress 
notes 
Screen in 12 months. 
Precontemplation 
Give patient 
"Quitting Smoking" 
From UTD/Quitine 
Contemplation 
Give patient "You Can Quit" 
folder/ "Assisting pts with 
smoking cessation" UTD and 
review 
Motivate to quit with "5 R's" 
RELEVANCE 
RISKS 
REWARDS 
ROADBLOCKS 
REPETITION 
Preparation Action 
Give patient "Assisting pts with smoking 
cessation" UTD. Review Cessation Materials and 
Resources 
ASSIST to quit: 
Counsel/Educate about quitting, assess desire for 
NRT, alert to other cessation resources 
Preparation: Set quit 
date in next 2 weeks 
Action: Quit 
today 
RX for Nicotine Patch +/- short acting nicotine 
product (gum, lozenge, inhaler) 
+/- Bupropion 
(Consider varenicline ifNRT failed) 
ARRANGE FOLLOW UP: 
Recommend I mo & 3 mo PCP 
Schedule call approx I week after appt 
or quit date 
If counseled 3-10 minutes, mark 99406 and ICD-9 "305.1" on billing sheet 
If counseled> I 0 minutes, mark 99407 and ICD-9 "305.1" on billing sheet 
81 
Maintenance 
Give patient 
"Preventing and 
Managing relapse in 
smokers" UTD 
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Nicotine patch 
Rx 
Nicotine gum 
OTC 
Stages of change 
Precontemplation - not thinking about quitting over the next 6 months 
Contemplation - thinking about quitting over the next 6 months 
Preparation - thinking about quitting within in the next 30 days 
Action - actively trying to quit 
Maintenance - no tobacco use in last 6 months 
Pharmacotherapy for Smoking Cessation 
Trade Name Starting Dose Full Dose/Duration 
Nicoderm CQ®; 
21 mg/d for 6 weeks 
Then 14 mg/d for 2 wks, then 
Habitrol®; Prostep® 7 mg /d for 2 wks 
15mg/d for 6 weeks (16 Then 10 mg x 2 wks, then 5 
Nicotrol® 
hrs/d) mg x2 wks 
Nicorette® Start on quit date. 1 tab/hr for 6 wks, then 1 
Nicotine lozenge 
< 25 cig/day use 2 mg tab tab/2 - 4 hrs for 2 wks, then 1 
Commit® ~ 25 cig/day use 4 mg tab tab/4 - 8 hrs for 2 wks 
OTC 
Nicotine nasal 
Nicotrol NS® 
1 to 2 doses/hr (most need Continue for 6 - 8 wks, then 
spray 
Rx 
minimum of 8 doses/day) taper gradually over 4 - 6 wks 
10 mg cartridges used over 
Nicotine inhaler 
20 mins (6 to 16 cartridges At least 6 cartridges/d for 3 -
Rx 
Nicotrol Inhaler® per day).Tx for 3 mo then 12 wks; max of 16 
decrease use over 6-12 cartridges/d 
weeks. 
Bupropion SR; 
Zyban®; 
Start 2 weeks before quit Continue 150 mg BID for 7 to 
Bupropion XL date; 150 mg QD for 3 12 weeks 
Rx 
Wellbutrin SR®; 
days; then BID-spaced 8 
Wellbutrin XL® 
(avoid w/ sz hx) hrs 
Start 1 week before quit Continue 1 mg BID weeks 2 
Varenicline date; Days 1-3 = 0.5mg through 12; may continue an 
Chantix® 
Rx QDay, days 4-7 = 0.5 mg additional 12 weeks if 
BID necessary 
82 
Average Cost 
$4.00/d, $120/mo 
$5.50/d, $165/mo 
$6.00/d, $180/mo 
$6.60/d, for low use. 
$17.00/d max 
usage. 
$6.50 /d, low use. 
$17.00/d max usage 
$2.50/d, $72/mo 
-$4.60/d, $138/mo 
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Common Adverse Effects to Smoking Cessation Products 
Nicotine Patch Nicotine gum or Nicotine nasal Nicotine inhaler Bupropion Varenicline 
lozenge spray 
• Local skin • Lightheadedness • Nasal or throat • Throat or mouth • Dry Mouth • Insomnia 
irritation • Nausea and irritation irritation • Nausea • Headache 
vomiting • Insomnia • Abnormal 
• Insomnia (w 24 • Sneezing • Unpleasant taste • Constipation dreams 
hr dosing) • Throat or mouth • Coughing • Cough • Agitation • Nausea 
Irritation • Eye irritation • Rhinitis • Change in mood • Vomiting 
• Vivid dreams • Runny nose • Dyspepsia or behavior • Stomach upset 
• Sleep • Hiccups • Patients with • Hiccups 
Disturbances • Indigestion allergies/asthma • Headache 
• Jaw discomfort • Patients with precaution: history 
should not use Asthma/CO PD contraindication: 
of psychiatric 
Should not use seizure disorder 
illness 
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CURRENT ISSUE 
Tobacco use is the leading 
preventable cause of death, 
disease, and disability in the US. 
About 1 in 5 adults smoke (45.3 
million) and, although smoking 
prevalence has declined from 
20.9% in 2005 to 19.3% in 2010, 
tobacco use is still the most 
common cause of preventable 
death and disease in the United 
States (Centers for Disease 
Control and prevention, 201 O). 
LOCAL CHALLENGE 
Primary care clinicians are in a 
strategic position to help their 
patients quit smoking. Currently, 
the primary care sites have access 
to the Quitline to distribute to 
patients during encounters. 
According to the 2008 New 
Guideline on Treating Tobacco use 
and Dependence, increasing 
evidence shows that screening 
and assessment practices such as 
expanding vital signs to include 
tobacco-use status, or other 
reminder system to ask about 
smoking significantly increase the 
rate of clinician intervention. 
Based on recent observations, the 
current recommended approach 
of the Quitline surveys with the 
suggested interventions have 
seemingly appeared to 
inadequately reduce tobacco 
usage at the primary care sites. 
A practice change is being proposed and 
entails the following: 
• A request for the addition of the 
patient's current smoking status as an 
entity of the vital $igns. 
• An assessment to determine the 
current stage of change according to 
the Transtheoretical Model. Changing 
or modifying a behavior that is 
addictive or potentially harmful is 
difficult for most people. The 
Transtheoretical Model (TTM) 
(Prochaska, Norcross, & DiClemente, 
1994) incorporates a compilation of 
previous theories, providing a 
framework for the stages of 
progression when deciding to change a 
problematic behavior. 
• Inclusion of an algorithm which will 
serve as a guide for primary care 
providers (PCPs) encompassing the 
TTM. 
These three components of the proposal 
would be in addition to the already 
established QuitLine that is currently being 
utilized. 
The goal of this practice change would be to 
provide improved patient care by increasing 
provider's adherence to the recommendations of 
a clinical practice guideline for the assessment 
and treatment of smoking cessation in the 
primary care setting. 
fobacco use 
91!Stages of 
pange 
TENNESSEE DEPARTMENT OF HEAL TH 
Bureau ol Heellh Services 
ADOLESCENT/ADULT PHYSICAL EXAMINATION (11 years and older) 
ll~Oft (If IPPUCeble) provided by: I PCP: 
CHIEF COllPl.AINT: I LMP: 
VITAL SIGNS: Ht. Wt. BMI Temp Pulse Resp BP 
ROS N AB Comments: ...... History & Allergles ~ 0 lmmunlDllone Aa ... Md 0 
·--·~ 
1. Gener.i 
2. E..., 
3. ENT/mouth 
4. Rao 
5. CV 
6. GI 
7. GU 
8. M111c:1*-llt111111 
9. Skin 
10. BrMll 
11. 
12. Endoc:tlne 
13. 
14. 
15. Psych ' 
Currently, the certified nurses' assistance gets the vital signs and records them in their appropriate slots. 
11 
TENNESSEE DEPARTMENT OF HEAL TH 
Bureau of H..nh SeNtcee 
PCP: 
UIP: 
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Sequatchie County Health Department 
Tobacco Cessation Algorithm 
No 
No action. 
Document in progress 
notes 
Screen in 12 months. 
Precontemplation 
Give patient 
"Quitting Smoking" 
From UTD/Quitine 
Contemplation 
Give patient "You Can Quit" 
folder/ "Assisting pts with 
smoking cessation" UTD and 
review 
Motivate to quit with "S R's" 
RELEVANCE 
RISKS 
REWARDS 
ROADBLOCKS 
REPETITION 
Yes 
Preparation Action 
Give patient "Assisting pts with smoking 
cessation" UTD. Review Cessation Materials and 
Resources 
ASSIST to quit: 
Counsel/Educate about quitting, assess desire for 
NRT, alert to other cessation resources 
Preparation: Set quit 
date in next 2 weeks 
Action: Quit 
today 
RX for Nicotine Patch +/- short acting nicotine 
product (gum, lozenge, inhaler) 
+/- Bupropion 
(Consider varenicline ifNRT failed) 
ARRANGE FOLLOW UP: 
Recommend I mo & 3 mo PCP 
Schedule call approx I week after appt 
or quit date 
If counseled 3-10 minutes, mark 99406 and ICD-9 "305.1" on billing sheet 
If counseled >10 minutes. mark 99407 and ICD-9 "305.1" on billiniz sheet 
96 
Maintenance 
Give patient 
"Preventing and 
Managing relapse in 
smokers" UTD 
PRACTICE CHANGE 
Nicotine patch 
Rx 
Nicotine gum 
OTC 
Nicotine lozenge 
OTC 
Nicotine nasal 
spray 
Rx 
Nicotine inhaler 
Rx 
Bupropion SR; 
Bupropion XL 
Rx 
(avoid w/ sz hx) 
Varenicline 
Rx 
llcotine Patch 
• Local skin 
irritation 
• Insomnia (w 24 
hr dosing) 
• Vivid dreams 
• Sleep 
disturbances 
Stages of change 
Precontemplation - not thinking about quitting over the next 6 months 
Contemplation - thinking about quitting over the next 6 months 
Preparation - thinking about quitting within in the next 30 days 
Action - actively trying to quit 
Maintenance - no tobacco use in last 6 months 
Ph th arm a co f s erapy or mo k" mg c f essa ion 
Trade Name Starting Dose Full Dose/Duration 
Nicoderm CQ®; 
21 mg/d for 6 weeks 
Then 14 mg/d for 2 wks, then 
Habitrol®; Prostep® 7 mg /d for 2 wks 
15mg/d for 6 weeks ( 16 Then 10 mg x 2 wks, then 5 
Nicotrol® 
hrs/d) mg x2wks 
Nicorette® Start on quit date. 1 tab/hr for 6 wks, then 1 
< 25 cig/day use 2 mg tab tab/2 - 4 hrs for 2 wks, then 1 
Commit® !: 25 cig/day use 4 mg tab tab/4 - 8 hrs for 2 wks 
Nicotrol NS® 
1 to 2 doses/hr (most need Continue for 6 - 8 wks, then 
minimum of 8 doses/day) taper gradually over 4 - 6 wks 
10 mg cartridges used over 
20 mins (6 to 16 cartridges At least 6 cartridges/d for 3 -
Nicotrol Inhaler® per day).Tx for 3 mo then 12 wks; max of 16 
decrease use over 6-12 cartridges/d 
weeks. 
Zyban®; 
Start 2 weeks before quit Continue 150 mg BID for 7 to 
date; 150 mg QD for 3 12 weeks 
Wellbutrin SR®; 
days; then BID-spaced 8 
Wellbutrin XL® 
hrs 
Start 1 week before quit Continue 1 mg BID weeks 2 
Chantix® 
date; Days 1-3 = 0.5mg through 12; may continue an 
QDay, days 4-7 = 0.5 mg additional 12 weeks if 
BID necessary 
Common Adverse Effects to Smoking Cessation Products 
Nicotine gum or Nicotine nasal Nicotine inhaler Bupropion 
lozenge spray 
• Lightheadedness • Nasal or throat • Throat or mouth • Dry Mouth 
• Nausea and irritation irritation • Nausea 
vomiting • Sneezing • Unpleasant taste • Insomnia 
• Throat or mouth • Coughing • Cough • Constipation 
Irritation • Eye irritation • Rhinitis • Agitation 
• Hiccups • Runny nose • Dyspepsia • Change in mood 
• Indigestion • Patients with • Hiccups or behavior 
• Jaw discomfort allergies/asthma • Headache 
should not use • Patients with contraindication: 
Asthma/COPD seizure disorder 
Should not use 
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Average Cost 
$4.00/d, $120/mo 
$5.50/d, $165/mo 
$6.00/d, $180/mo 
$6.60/d, for low use. 
$17.00/d max 
usage. 
$6.50 /d, low use. 
$17.00/d max usage 
$2.50/d, $72/mo 
-$4.60/d, $138/mo 
Varenicline 
• Insomnia 
• Headache 
• Abnormal 
dreams 
• Nausea 
• Vomiting 
• Stomach upset 
precaution: histol) 
of psychiatric 
illness 
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SUMMARY 
Tennessee Department of Health Mission: To protect, promote, and improve the health 
and prosperity of people in Tennessee. 
Increasing evidence shows that screening and assessment practices such as expanding 
vital signs to include tobacco-use status or other reminder system to ask about smoking 
significantly increases the rate of clinician intervention. 
The primary care setting is an ideal location to promote smoking cessation through 
counseling and pharmacological aids. The US Preventive Services Task Force 
recommends asking about tobacco use in all adults which may be accomplished by using 
the 5-A model to assist PCP's implement Tennessee Department of Health's cessation 
protocol. This system encourages clinicians to ask patients about their smoking status, 
advise smokers to quit, assess their readiness to quit, assist them with their smoking 
cessation effort, and to arrange for follow-up visits or contact (Fiore, M.C., Jaen, C., & 
Baker, T., et al., 2008). 
Patients who use tobacco but are unwilling to quit should be approached with the "5 R's" 
of motivational intervention (Relevance, Risks, Rewards, Roadblocks, and Repetition) 
(Fiore, M.C., Jaen, C., & Baker, T., et al., 2008). 
The developed evidence-based treatment protocol algorithm is an easy-to-follow tool that 
facilitates the incorporation of smoking cessation counseling during patient encounters. 
During brief encounters, this algorithm may provide a concise pathway for providers to 
follow in addition to the ability to bill for reimbursable services using the outlined CPT 
codes (CPT, 2014). 
Regarding cost, these three components of the proposal would eventually prove to be 
perhaps a cost benefit in terms of a decrease in tobacco usage and consequently a 
reduction in tobacco related illnesses and diseases due to the easy accessibility to the 
providers. The projected miniscule cost on acceptance of this proposal may entail 
obtaining additional resources from the CDC's publication department regarding 
handouts or brochures for encouraging and maintaining smoking cessation in addition to 
the QuitLine. 
This project manager is respectfully seeking permission to implement the above practice 
change proposal at all three primary care sites for a pilot study for approximately six 
PRACTICE CHANGE 
months. To determine efficacy of this practice change proposal, a follow-up six months 
"Patient Tobacco Survey" would also be requested to then be evaluated by the 
appropriate personnel deemed by the Southeast Regional Health Department. 
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1. INTRODUCTION 
The primary purpose of this project is to address the growing smoking epidemic concerlf in the 
Southeast Region of Tennessee with adults aged 19 to 64 years who are uninsured who seek 
care at the local health departments, specifically Sequatchie County Health Department. A 
practice change is proposed and would entail a request for the addition of the patient's current 
smoking status as an entity of the vital signs, and an assessment to determine the current stage 
of change according to the Transtheoretical Model. Changing or modifying a behavior that is 
addictive or potentially harmful is difficult for most people. 
Evaluation Purpose 
• What does this evaluation strive to achieve? 
Determine the efficacy of the added component to the vital signs section, and address 
individual needs regarding stages of change relating to tobacco use. 
• What is the purpose of this evaluation? 
The purpose of this evaluation is to attempt to reduce the amount of smokers who are 
uninsured and live in rural communities. A good evaluation does not merely gather 
accurate evidence and draw valid conclusions, but produces results that are used to make 
a difference regarding smoking cessation in this community which is the ultimate goal 
• How will findings from the evaluation be used? 
The ultimate purpose of a program evaluation is to use the information to improve 
specific programs. The purpose initially identified early in the evaluation process should 
guide the use of the evaluation results. The evaluation results can be used to demonstrate 
the effectiveness of the program, identify ways to improve the current program, modify 
program planning, and demonstrate accountability. Dissemination involves 
communicating evaluation procedures or lessons learned to relevant audiences in a 
timely, unbiased, and consistent manner. Regardless of how communications are 
structured, the goal for dissemination is to achieve full disclosure and impartial reporting 
(CDC, 2011). 
Information will be disseminated among the other primary care sites in the Southeast 
region and eventually across the state of Tennessee once deemed effective, valuable, and 
successful. 
Stakeholders 
• Who are the stakeholders for this evaluation? 
The Regional Medical Director, the Medical Director of Community Health Services, and 
the Director of Office of Quality Improvement. 
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Tab\e F .1. Stakeholder Assessment and Engagement Plan 
Stakeholder Stakeholder Interest or Role in the 
How and 
When to Name Category Perspective Evaluation Engage 
Medical Primary Budget for Gives the initial Initially and at 
Director of Stakeholder direct and and final the completion 
Community indirect costs acceptance of the of the project 
Health Services Proposal 
Regional Secondary Works From a clinical Throughout the 
Medical Stakeholder closely with perspective, able entire process 
Director the providers to view firsthand 
the process from 
the provider's 
perspective 
Director of Tertiary Overall Collaborates with Initially for the 
Office of Stakeholder Quality the Medical IRB process 
Quality improvement Directors of and at the 
Improvement for the Community completion 
uninsured Health Services 
patients 
2. What is the goal? 
The goal of this practice change would be to provide improved patient care by increasing 
provider's adherence to the recommendations of a clinical practice guideline for the assessment 
and treatment of smoking cessation in the primary care setting. 
Need 
• What is the need for what you are evaluating? 
Reduction in tobacco use 
Target Population 
• Uninsured or underinsured adults ages 19-64 years 
Stage of Development 
• Is it in the planning or implementation stage? 
This is in the planning stage 
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Resources/Inputs 
What resources are available to support what is being evaluated? 
Time 
Activities 
• What specific activities are undertaken (or planned) to achieve the outcomes? 
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Addition of tobacco use assessment to be included in the vital signs section of the 
progress notes, inclusion of an assessment of change using the Transtheoretical Model, 
and a concise algorithm to assist the provider at the point of care. 
Outputs 
• What are some of the outcomes? 
Outcomes 
The increased number of calls to the QuitLine, or use of prescribed or OTC 
medications. 
• What are the program's intended outcomes? 
Increased knowledge and use of cessation services 
• What do you ultimately want to change as a result of your activities? 
A reduction in tobacco related mortality and morbidity 
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Logic Model 
Promoting Smoking Cessation Among Young People and Adults 
Logic model for promoting smoking cessation among young people and adults 
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3. EVALUATION DESIGN 
Stakeholder Needs 
• Who will use the evaluation findings? 
0. 
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The Regional Medical Director, the Medical Director of Community Health Services, and 
the Director of Office of Quality Improvement. 
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What do they need to learn from the evaluation? 
The major issue is to approach tobacco users from different perspectives based on their 
current stage of change. Determining if there is a reduction in tobacco use with the use of 
the tobacco assessment in the vital signs section, and the appreciation of the concise 
algorithm. 
• What do intended users view as credible information? 
Evidence based research 
Evaluation Design 
• What is the design for this evaluation? 
The design for this proposal for a practice change would look retrospectively at the quit 
rate prior and the quit rate after implementation of the change- both for a six month 
period. This comparison would be determined by the tobacco surveys done on initial 
and annual visits. 
DATA COLLECTION 
Data Collection Methods 
• Will new data be collected and compiled to answer the evaluation questions or will 
secondary data be used? 
New data will be collected for 6 months after implementation; secondary data will be 
used for retrospective analysis and will also be obtained from the data base analysis 
archived in the electronic system 
• What methods will be used to collect or acquire the data? 
Tobacco surveys done annually and on initial encounters, unstructured self-report 
utilizing a three question questioner, informal conversation done during the actual 
encounters, and chart reviews. 
• Will a sample be used? If so, how will the sample be selected? 
Purposive Sampling: Only smokers who are actually motivated and willing to quit 
smoking assessed during encounters for follow up return visits, initial and annual visits. 
Patients generally are open and honest in terms of their need or desire to quit. 
• How will the data be protected? 
Charts are currently paper and with strict observance of HIPP A compliance with coding 
in Excel utilizing a numerical and letter system to de-identify the charts on the project 
manager's computer which is password protected. Charts are locked in an office every 
evening and accessed by the office supervisor, medical director and project manager. 
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Paper surveys will be distributed and a focus group interview will be used to obtain in-
depth information from a group of participants who have decreased their daily cigarette 
amount to those who have gained the victory over tobacco use information of their 
intervention. No more than ten open-ended questions will be used and presented to 
approximately four to fifteen people who have never had prior interaction. A moderator 
will be determined and an informed consent will be obtained prior to audio recordings. 
5. Data Analysis and Interpretation 
Indicators and Standards 
• What are some measurable or observable elements that can tell you about the 
performance of what is being evaluated? 
During monthly or quarterly follow up visits, a reduction in the amount of cigarettes 
smoked, or patients who have actually quit tobacco use. An assessment of 
documentation compliance will be done to the other practitioners at their sites. 
• What constitutes "success"? 
Determining an awareness of stage of change from the providers' perspective and to 
assist with subsequent visits, and a reduction in the quantity of cigarettes smoked on a 
daily basis to total abstinence. 
Analysis 
• What method will you use to analyze your data 
Content analysis will be used to analyze the qualitative data obtained from interviews, 
focus groups, and comments written on participant surveys. Descriptive 
Statistics of the data may include frequencies, means and summary statistics. To identify 
any significant changes in the tobacco survey and patients' smoking cessation status, 
possible pre and post intervention measures would be analyzed with the paired t test. 
Interpretation 
• Who will you involve in drawing, interpreting, and justifying conclusions? 
The epidemiologist and the Director of the Office of Quality Improvement 
6. COMMUNICATING 
• What actions will be taken to promote evaluation use? 
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Presentations and open discussions at the quarterly primary care meetings 
• How will evaluation findings be used? 
After the pilot study, the amended progress notes with the algorithm will be a permanent 
part of the records 
• Who is responsible for implementing evaluation recommendations? 
The Regional Medical Director 
Communication 
• What methods will you use to communicate with evaluation stakeholders? 
A PowerPoint presentation at the quarterly primary care meetings. 
7. EVALUATION MANAGEMENT 
.Evaluation Team 
• Who will implement this evaluation? 
Medical director, RN's, APN's and MD's 
Roles and Responsibilities of the Evaluation Team Members 
Individual Title or Role Responsibilities 
Medical Director Responsible for the Oversees the clinical aspects for 
flow of activities in the providers 
various primary care 
sites 
APN's/MD's Primary Care Point of care services 
Practitioners 
Charge Nurse/RN In charge of the Oversees the CNA's and their 
CNA's documentations 
Data Collection Management 
• What data will be collected? 
Comparing the results of the Tobacco Survey before and after the implementation of the 
proposed practice change in the electronic system 
• What activities are needed to carry out the data collection successfully? When should 
each of these activities be completed? 
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After six months of the pilot study, a comparison will be made to determine the efficacy 
of the change in the progress notes, and a formal discussion with the providers to assess 
the feasibility of the proposed change. 
Data Analysis Management 
• What data will be analyzed, how, and when? 
Content analysis will be used to analyze the qualitative data obtained from interviews, 
focus groups, and comments written on participant surveys. The content analysis will 
determine the specific concerns for the practice change, using a simple, systematic, 
verifiable process. Each interview, focus group discussion and participant survey 
comment will be transcribed and each line numbered. 
Table F.7. Data Analysis Plan 
Analysis to Be Performed Data to Be Person(s) Due Date Analyzed Responsible 
Content Analysis Tobacco surveys Project manager 
Correlation procedures Information gained Project manager 
from the providers and Medical 
Director 
Communicating and Reporting Management 
• What are the target audiences for reporting the progress made on the evaluation and/or 
evaluation findings? 
MD's, APN's, RN's, and the Regional Medical Director 
• What is the purpose of the communications with this audience? 
To ensure knowledge of the current evidence based information for assisting and 
empowering our smoking population 
• What is the most appropriate type of communication method to use with this audience, 
for this purpose? 
Open discussions, oral presentations, at the quarterly primary care meetings 
• When will the communication take place? 
Summer of 2014 
Timeline 
• When will planning and administrative tasks occur? 
After IRB approval 
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• When will any pilot testing occur? 
Once approval of the practice change has been determined 
• When will formal data collection and analysis tasks occur? 
After approximately 6 months 
• When will information dissemination tasks occur? 
After review and discussion of the proposal, acceptance and then implementation 
Evaluation Budget 
• What is the cost for this evaluation? 
The projected miniscule cost on acceptance of this proposal may entail obtaining 
additional resources from the CDC's publication department regarding handouts or 
brochures for encouraging and maintaining smoking cessation in addition to the 
QuitLine. Additional costs may also include reprinting charts, surveys, questioners and 
additional personal time by the project manager. 
